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Abstract 
 
Endovascular aneurysm repair (EVAR) has become increasingly popular over the last 
few years, but is associated with complications such as endoleaks, graft fracture and 
migration (Ouriel, Clair et al. 2003), which prompt urgent intervention. This has 
necessitated lifelong follow up of patients with CT scans at regular intervals, which 
has significant cost implications and exposes patients to a large radiation dose. 
Duplex ultrasound has been proposed as an alternative (Henao, Hodge et al. 2006, 
Sandford, Bown et al. 2006), but substantial variation has been reported in the 
literature in terms of its sensitivity and specificity for detecting complications.  
The aim of this research project was to assess the limitations of duplex ultrasound and 
to establish whether its sensitivity and specificity in routine clinical imaging for the 
surveillance of patients post EVAR could be improved to the same level as CT. Novel 
ultrasound blood and tissue mimicking phantoms were used to assess the limits of 
ultrasound, and the effects of operator experience, in detecting complications 
(Ramnarine, Nassiri et al. 1998, Teirlinck, Bezemer et al. 1998, Madsen, Dong et al. 
1999, Surry, Austin et al. 2004).   
The study was divided into a clinical arm and a laboratory-based arm. The clinical 
arm compared results from CT and Duplex ultrasound for patients post EVAR. In the 
laboratory, novel tissue and blood mimicking ultrasound phantoms with known 
geometry, material and blood flow parameters were used to assess the limitations of 
duplex ultrasound, independent of the operator. The effect of operator experience on 
the reliable detection and classification of complications was also assessed. In 
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addition, machine dependent parameters were studied to optimise the sensitivity of 
duplex ultrasound in EVAR evaluations. 
The results of our laboratory experiments demonstrated that endoleak detection with 
duplex ultrasound proved more difficult with increasing depth of the endoleak from 
the viewing position and when the endoleak was in a plane distal to the aortic flow. 
Our results also demonstrated an increasing trend toward flow detection with 
increasing flow rates of the endoleak. Our clinical arm corroborated the findings of 
the laboratory arm with endoleaks that were missed on DUS being identified as slow 
flow endoleaks located posteriorly and in direct apposition with the stent graft. 
Although our results did not unequivocally demonstrate the superiority of DUS 
compared to CT, there was a clear trend towards diagnosis of all endoleaks that 
required intervention. Our experiments support the use of DUS for the surveillance of 
patients post EVAR in a complimentary role to CT, thus reducing the substantial 
radiation exposure for these patients and the associated cost burden to health 
providers.
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INTRODUCTION 
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Abdominal aortic aneurysms 
 
An aneurysm is defined as an excessive localized enlargement of an artery, caused by 
a weakness of its wall, by at least half of its original diameter (Sakalihasan, Limet et 
al. 2005, Norman S Williams, Bulstrode et al. 2008). They can affect any artery in the 
human body but the majority are seen in the abdominal aorta.  
The aorta is the main artery of the human body that originates from the left ventricle 
of the heart and terminates by dividing into the common iliac arteries that are 
responsible for blood supply to the pelvis and legs. Anatomically the aorta is 
classified into the thoracic and abdominal parts, which as the names suggest, are 
present in the chest and abdominal cavities respectively. The thoracic aorta is further 
classified into the ascending aorta, the arch of the aorta and the descending aorta. 
The abdominal aorta supplies blood to the abdominal organs and is the predominant 
artery to be affected by aneurysm formation. Abdominal aortic aneurysms are 
traditionally classified according to their anatomical relationship with the origin of the 
renal arteries into supra renal, juxta renal and infra renal varieties. Supra and infra 
renal aneurysms affect parts of the aorta above and below the origins of the renal 
arteries, whilst juxta renal aneurysms involve the origins of the renal arteries. Most 
abdominal aortic aneurysms are infra renal and usually terminate proximal to the 
aortic bifurcation into the common iliac arteries.  
Aneurysms have also been classified as follows (Norman S Williams, Bulstrode et al. 
2008)  
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a. True and False: True aneurysms involve all the three layers of the arterial wall 
namely intima, media and adventitia. False aneurysms are predominantly 
traumatic in origin and do not involve all the layers of the arterial wall.   
b. Congenital or acquired: Berry aneurysms affecting the intracranial circulation 
are inherited aneurysms, though they usually manifest in adult life. 
c. Based on aetiology: Aneurysms have been divided into atherosclerotic, 
mycotic, syphilitic, inflammatory, traumatic and congenital. Atherosclerosis is 
thought to be the underlying process in most aneurysms. Mycotic aneurysms 
occur as a consequence of an infective process leading to the destruction of the 
arterial wall. Tertiary syphilis is associated with thoracic and abdominal 
aneurysms. Inflammatory aneurysms are a distinct entity and are so named due 
to the presence of an intense peri-aortic inflammatory response.  
d. Based on anatomical location: Aneurysms can be classified on the basis of 
their anatomic location into intra-cranial, thoracic, abdominal or peripheral 
aneurysms. 
e. Based on morphology: Aneurysms can also be classified according to their 
shape into the more common fusiform type, which have a uniform shape with 
symmetrical and circumferential involvement of the aortic wall, or the 
saccular type that are more localised dilatations and appear as an out pouching 
of only a portion of the arterial wall. Dissecting aneurysms occur as a result of 
deficiency of the arterial media as occurs in syphilis, Marfan’s syndrome and 
Erdheim’s cystic medial necrosis. 
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Pathophysiology 
 
Aortic walls are made up of concentric layers of smooth muscle cells and the proteins 
elastin and collagen. Together, these elements are responsible for the visco-elastic 
properties of the arterial wall. Remodelling is a process by which tissues continually 
regenerate; older tissue components are replaced by newer ones. In normal aortic 
tissue, remodelling is a result of a balance between proteolytic enzymes such as 
metalloproteinases, cathepsins, chymase and tryptase; and their inhibitors such as 
tissue inhibitors of metalloproteinases (TIMP). 
Aneurysm formation is a complex process that involves destructive remodelling of 
aortic tissues throughout the affected segment of the aorta. Aneurysms are 
characterised by increased local production of proteolytic enzymes and reduced 
expression of their inhibitors, thus causing degradation of elastin and collagen in the 
media and the adventitia of vessel walls. This is also accompanied by the loss of 
medial smooth muscle cells, thinning of vessel walls and transmural infiltration by 
lymphocytes and macrophages.  
The exact mechanisms of aneurysm formation are still poorly understood, however, 
the recruitment of inflammatory cells into the adventitial and medial layers of the 
aortic wall is thought to be an early step in their development. The trigger for this 
influx of inflammatory cells is as yet unknown. It has been postulated that molecular 
mimicry might play a role in this initial lymphomonoytic response (Hirose and Tilson 
2001). Various factors such as vascular injury, elastin degradation and infections 
particularly with organisms such as Chlamydia pneumonia have been implicated in 
bringing about the inflammatory influx (Kuivaniemi, Platsoucas et al. 2008). 
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Recruitment of inflammatory cells is associated with increased levels of cytokines and 
interleukins that are responsible for the activation of proteolytic enzymes and reduced 
expression of their inhibitors. Cells within the inflammatory exudate have also been 
recognised to produce Fas ligand and Fas associated phosphatase-1 (FAP-1). Within 
aneurysmal aortic tissue, Fas and FAP-1 have been associated with the regulation of 
apoptosis of vascular smooth muscle cells and other lymphocytes. Apoptosis of these 
cells is thought to contribute to aneurysm formation (Hirose and Tilson 2001, Curci 
and Thompson 2004, Lindholt and Shi 2006). Fas ligand is a transmembrane protein 
that is thought to regulate apoptosis of medial smooth muscle cells. FAP-1 is a 
tyrosine phosphatase that interacts with the cytosolic pool of Fas. Expression of FAP-
1 has been postulated to be coexistent with attenuation of Fas export to the cell 
surface and subsequent reduction in Fas related cytotoxicity (Ivanov, Lopez Bergami 
et al. 2003).  
Imbalances in remodelling bring about proteolytic fragmentation of elastic fibres and 
a progressive loss in the concentration of elastin in the media of vessel walls until 
rupture. In the absence of elastic fibres, the adventitia with predominant collagen is 
responsible for aortic vessel resistance. It has been postulated that collagen 
degradation is the ultimate cause of aneurysm rupture (Dobrin and Mrkvicka 1994).  
 
Atherosclerosis and abdominal aortic aneurysms 
 
The aneurysmal aorta is usually associated with the presence of atherosclerotic 
changes. Atherosclerotic plaques have been associated with medial thinning and 
compensatory arterial enlargement. It has been postulated that segments of the 
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abdominal aorta afflicted with atherosclerotic plaques may predispose to aneurysm 
formation. Traditionally, aneurysmal change has been regarded as a consequence of 
atherosclerosis. However, this association has been challenged in recent years. A 
second theory suggests that the development of AAA and atherosclerosis is 
independent. Some recent authors have postulated that both AAA and atherosclerosis 
might develop individually but may stimulate the development of the other. Other 
studies have suggested that both occlusive and aneurysmal disease may have similar 
origins but the natural progression is divergent (Golledge and Norman 2010, Johnsen, 
Forsdahl et al. 2010).  
It is still poorly understood as to why atherosclerotic plaques lead to aneurysmal 
change in certain individuals and occlusive disease in others. Autopsy studies have 
demonstrated that the abdominal aortic diameter increases with increasing 
atherosclerotic plaque, that is in turn associated with medial thinning and loss of 
native aortic architecture. Xu et al (Xu, Zarins et al. 2001) suggested that a balance 
between plaque stability and progression might decide upon which path the aorta 
takes – occlusive or aneurysmal. In cases where plaques demonstrate repeated 
progression and erosion, the consequential wall thinning renders the aortic wall 
incapable of sustaining wall stresses and resulting in aneurysmal dilatation. In cases 
of stable plaques however, the result is occlusive disease. 
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Epidemiology and Risk Factors 
 
Abdominal aortic aneurysms affect 4-10% of people older than 60 years of age 
(Hellmann, Grand et al. 2007).  The prevalence of these aneurysms increases with age 
and varies between 1.3 – 8.9% in men and 1 – 2.2% in women.  
Age 
The prevalence of abdominal aortic aneurysms tends to increase with increasing age. 
Most studies describe a sharp rise in the prevalence of AAA’s after the age of 60. 
Under the age of 60, its prevalence is thought to be of the order of 1%, and above the 
age of 80 this appears to plateau. 
Sex 
Abdominal aortic aneurysms are three to four times more common in men as 
compared to women. In women, these aneurysms are associated with a far worse 
prognosis than men. The UK small aneurysm trial reported a 4-fold higher incidence 
of rupture in women compared to men (2002). Also, ruptures tend to occur at a 
smaller aneurysm diameter in women than in men. 
Race 
Evidence to date suggests that Abdominal Aortic Aneurysms tend to affect the 
Northern European and North American population more than Asians or Africans 
(Blanchard 1999). 
Smoking 
By far the strongest association of abdominal aortic aneurysms is with smoking. The 
relative risk for current smokers is at least 2. Also, the association of ever smoking 
with AA is 2.5 times greater than for Coronary Artery Disease (CAD). Continued 
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smoking has also been associated with increased AAA expansion, increased rupture 
rates and generally a worse prognosis (Blanchard 1999).  
Family History 
Approximately 1% to 5% of patients with abdominal aortic aneurysms have a positive 
family history. Patients with a family history of abdominal aortic aneurysms have also 
been related to a higher risk of aneurysm rupture (Sakalihasan, Limet et al. 2005). 
Hypercholesterolemia 
Elevated serum cholesterol levels were found to be associated with the presence of 
AAAs in several studies (Blanchard 1999, Sakalihasan, Limet et al. 2005). This has 
been explained as a connection with atherosclerosis, although some studies do suggest 
a direct inflammatory effect. 
Hypertension 
Hypertension has been shown to have a weak association with the presence of AAA’s 
(Sakalihasan, Limet et al. 2005). 
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Natural History 
 
The vast majority of patients affected by abdominal aortic aneurysms remain 
asymptomatic, most patients being diagnosed either incidentally or by aneurysm 
screening programmes. Symptoms that have been attributed to the presence of 
abdominal aortic aneurysms include low back pain and chronic vague abdominal pain. 
Some patients can present with complications such as distal embolisation, aorto-
enteric or aorto-caval fistulation, and symptoms of compression of abdominal viscera 
or with rupture of the aneurysm. 
Aneurysm rupture carries a high risk of mortality. Despite improvement in surgical 
mortality rates for elective abdominal aortic aneurysm repair, the operative mortality 
rates for ruptured AAA’s has remained high. The operative mortality rates for 
ruptured abdominal aortic aneurysms have been quoted at approximately 50% (Bown, 
Sutton et al. 2002), although both the incidence of ruptured AAA (Anjum, von 
Allmen et al. 2012) and operative mortality (Bown, Sutton et al. 2002) have been 
declining over the years. Combined pre-hospital and operative mortality rates from 
ruptured AAA’s approaches 80%.  The risk of aneurysm rupture is directly 
proportional to the size of the aneurysm. Aneurysms < 4 cm in size carry an annual 
rupture risk of 0.3%, those between 4.0 and 4.9 cm aneurysm are associated with a 
1.5% annual risk of rupture, those with a 5.0 to 5.9 cm aneurysm carry an annual 
rupture risk of 3%. The annual risk of rupture approaches 25% for aneurysms greater 
than 8 cm in size. Heavy smokers, patients on steroids for COPD, patients with poorly 
controlled hypertension; those with a strong family history of aneurysms and those 
with very eccentric shaped aneurysms are also at an increased risk of rupture (Lederle, 
Nelson et al. 2003, Sakalihasan, Limet et al. 2005). 
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Rapid expansion of aneurysms is thought to precede rupture and has been observed in 
aneurysms independent of their initial size. Factors other than aneurysm size, thus, 
have also been thought to be responsible for rupture. Increasing serum levels of 
MMP-9, α1-antitrypsin and avid FDG uptake on PET scanning have been suggested 
as tools by some authors to predict aneurysm rupture (Sakalihasan, Limet et al. 2005).  
Aneurysm growth rates vary between 0.3 and 0.57 cm per year. Large aneurysms (>5 
cm in size) grow more rapidly than smaller ones. Current guidance advises surgical 
repair in patients with an aneurysm size greater than 5.5 cm or those with an 
expansion rate of more than 1 cm/year. 
Investigators have assessed the risk benefit ratio of intervention for small sized 
aneurysms. The UK small aneurysm trial (The UK small aneurysm trial participants 
1998) randomly assigned 1090 patients with asymptomatic, infra renal abdominal 
aortic aneurysms 4 - 5.5 cm in size, to either on-going surveillance or early elective 
open surgery. Their results did not reveal any overall survival advantage in patients 
undergoing early surgery as opposed to being on ultrasonic surveillance. Similar 
results were also obtained by the North American ADAM trial (Lederle, Wilson et al. 
2002) that randomised 1136 patients with aneurysms 4 - 5.5 cm in size to surveillance 
or surgery. There was no reported difference in the primary outcome measure of all 
cause mortality between the two groups. These studies were responsible for the 
accepted current practice suggesting operative intervention for suitable patients with 
aneurysms of 5.5 cm and above or with expansion rates of more than 1 cm/year. 
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The inflammatory abdominal aortic aneurysm  
 
Approximately 3-10% of patients with abdominal aortic aneurysms have been 
identified as being afflicted with the inflammatory variety. This distinct category was 
first identified by Walker et al in 1972 (Walker, Bloor et al. 1972). These aneurysms 
are characterised by three pathologic features: (1) a thickened aneurysm wall, (2) 
periaortic and retroperitoneal fibrosis, and (3) extensive adhesions involving adjacent 
structures. The expansion of the aneurysm wall is predominantly noted to be in the 
adventitia of the aortic wall. This expansion is secondary to an extensive 
inflammatory reaction brought about by plasma cells, lymphocytes, macrophages and 
up regulation of inflammatory cytokines including interleukins 2, 4, 1α and adhesion 
molecules. The periaortic fibrosis associated with inflammatory aortic aneurysms 
tends to involve the anterior and lateral walls of the aneurysm; the posterior wall is 
usually spared. This feature of inflammatory aneurysms helps to distinguish them 
from other causes of retroperitoneal fibrosis such as bladder malignancies. 
The association of smoking and male sex, risk factors for abdominal aortic aneurysms, 
is even stronger for inflammatory abdominal aortic aneurysms (Pennell, Hollier et al. 
1985, Hellmann, Grand et al. 2007, Palmisano and Vaglio 2009). There appears to be 
a stronger familial clustering but the risk of rupture associated with these aneurysms 
appears to be less than for the non-inflammatory variety (Hellmann, Grand et al. 
2007). Patients with these aneurysms also tend to be younger and usually are 
symptomatic with back and abdominal pain.  
Some authors have reported on the non-operative management of inflammatory 
abdominal aortic aneurysms with corticosteroids or immunosuppressant agents such 
as methotrexate, cyclophosphamide and azathioprine (Hellmann, Grand et al. 2007, 
	   25	  
Palmisano and Vaglio 2009). However there is generalised agreement in that these 
approaches do not alter the long-term progression and risk of rupture of this variety of 
aneurysms. Surgical management of these aneurysms is the same that of the non-
inflammatory type; repair being recommended when ≥5.5 cm in size. 
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Operative options 
 
Surgery has been the mainstay of treatment of aneurysms. Options available for 
surgical repair of abdominal aortic aneurysms include 
1. Conventional open repair 
2. Endovascular repair 
3. Laparoscopic repair 
Open surgery involves replacement of the aneurysmal segment of the aorta with a 
synthetic graft utilising either a midline/transverse laparotomy or a retroperitoneal 
approach. The choice of graft used (either a straight graft or a trouser graft) depends 
upon the involvement of the iliac arteries with the aneurysm. In cases where the 
aneurysm involves the iliac arteries, a bifurcated (trouser) graft may be used; the waist 
of the graft being suture to the aorta proximal to the origin of the aneurysm and the 
trouser ends being sutured to the iliac arteries. If the aneurysm does not involve the 
iliac arteries, a straight graft can be used, replacing the aneurysmal segment of the 
aorta. 
Abdominal aneurysm repair is a major surgical undertaking, associated with a 2-5% 
mortality rate. Other significant complications associated with open surgery include 
chest infection, myocardial infarction, renal failure, bowel ischemia, bowel 
obstruction, incisional hernias, limb ischemia, amputation, wound infections and 
paraesthesia.    
Endovascular and laparoscopic aneurysm repair are minimally invasive alternatives to 
open surgery. Endovascular repair involves insertion of a stent-graft across the 
	   27	  
aneurysm from within. This excludes the aneurysm from the circulation. The 
aneurysm is accessed though the common femoral arteries either through groin 
incisions or percutaneously. A stent-graft is then deployed across the aneurysm, 
excluding it from the circulation. In cases where the femoral or iliac arterial diameter 
is too small to introduce the stent-graft, a surgical conduit fashioned on to the iliac 
artery may be used to deploy the device. This conduit is usually sutured onto either 
the common or external iliac artery utilising a retroperitoneal approach. As described 
subsequently, not all patients though, would be suitable for endovascular repair. The 
anatomy of the aneurysm neck is the most important determinant of suitability for 
EVAR. 
Laparoscopic repair involves the replacement of the aneurysmal aorta with either a 
tube or bifurcated graft using either hand-assisted laparoscopic surgery (HALS) or 
total laparoscopic surgery (TLS). For HALS, apart from small incisions for the 
laparoscope and instruments, a mini midline laparotomy wound is used to assist the 
repair, whereas for TLS the whole repair is achieved laparoscopically. 
Endovascular and laparoscopic repair are associated with reduced in-patient length of 
stay and recent trials have reported similar or better results compared to open surgery 
(EVAR trial participants 2005, EVAR trial participants 2005).  
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 Endovascular abdominal aortic aneurysm repair 
 
Endovascular Aneurysm Repair (EVAR) was first introduced by Parodi et al (Parodi, 
Palmaz et al. 1991) in 1989 and has gained popularity over the years. The procedure 
involves placement of a stent-graft across the aneurysm from within the circulation. 
The EVAR device is placed into the aorta through the femoral arteries that can be 
accessed by means of a surgical cut down or by utilising percutaneous access. The 
EVAR device forms a seal with the aorta proximal to the aneurysm and the iliac 
arteries distal to the aneurysm – the proximal and distal seal zones.  
 
The evidence for EVAR 
 
Intuitively, EVAR is a less invasive procedure as compared to standard open surgery; 
however, patients with abdominal aortic aneurysms are complex and often have 
multiple co-morbidities that makes aneurysm repair, open or endovascular, a high-risk 
procedure.  
Several large trials have compared outcomes between endovascular and open repair of 
aneurysms (Prinissen, Verhoeven et al. 2004, EVAR trial participants 2005, Lederle, 
Freischalag et al. 2009, EVAR trial participants 2010). The UK EVAR trial was a 
large multicentre randomised controlled trial that evaluated outcomes related to 
mortality, durability, health related quality of life and cost benefits between patients 
undergoing endovascular and open repair of their abdominal aortic aneurysms. 1252 
patients >60 years of age with aneurysms >5.5 cm in size and with suitable anatomy, 
were randomised to either open or endovascular repair. 30-day operative mortality 
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was 1.8% in the EVAR group and 4.3% in the open repair group (p=0.02). However, 
by the end of the follow up period, this early aneurysm-related death benefit had been 
lost (p=0.73). This was partly blamed upon endograft related ruptures.  Also, there 
was no difference in all cause mortality between the 2 groups (p=0.72). Kaplan-Meier 
analysis revealed the 2 curves for all cause mortality converging at 2 years and for 
aneurysm related mortality converging at 6 years.  There was a significantly higher re-
intervention rate in the endovascular group (3-4 times higher in the EVAR group 
compared to the open group) that also translated to higher costs being ascribed to 
endovascular aneurysm repair as opposed to open repair.  
The DREAM triallists have reported similar results, (Prinissen, Verhoeven et al. 2004, 
De Bruin, Baas et al. 2010) with the initial survival benefit from EVAR being lost at 
long-term follow up (cumulative survival rates 69.9% for open repair and 68.9% for 
endovascular repair at 6 years). Re-intervention rates, again, followed precedents 
from other trials with rates being significantly higher in the endovascular group. 
The OVER trial, a large North American trial, published their 2-year follow up results 
comparing open and endovascular approaches for abdominal aortic aneurysm repairs 
in 2009 (Lederle, Freischalag et al. 2009). Long-term results were published in 2012 
(Lederle, Freischlag et al. 2012). As with the other trials, their primary outcome was 
all cause mortality with secondary outcome measures being procedural failure, short-
term morbidity, length of hospital stay, health related quality of life and erectile 
dysfunction. They reported a sustained peri-operative mortality reduction with 
endovascular repair up to a period of 3 years post EVAR; survival benefits being the 
same in both groups thereafter. An interesting finding from this trial was the reported 
higher long-term survival in younger patients who had undergone endovascular repair 
compared to older patients.  
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All the large comparative EVAR trials have identified a peri-operative mortality 
reduction with endovascular aneurysm repair. Long-term results however suggest that 
this benefit is lost by about 2-3 years time, with survival rates being similar in both 
arms. Endovascular repair has also been associated with higher costs overall due to a 
higher re-intervention rate.  
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Suitability for EVAR - Anatomical requirements 
 
Not all aneurysms are suitable for endovascular repair. Several anatomic criteria have 
been described to assess suitability of aneurysm morphology for endovascular repair. 
These include aneurysm neck length, diameter, angulation, thrombus burden; iliac 
landing zone length, diameter and iliac vessel tortuosity. 
 
Neck morphology 
The neck of the aneurysm is the length of normal calibre aorta distal to the lowermost 
renal artery and the commencement of the aneurysm. This is the proximal attachment 
area of the EVAR stent-graft (proximal sealing zone). Most manufacturers 
recommend a minimum aneurysm neck length of 1 – 1.5 cm for the device to be able 
to achieve an adequate seal with the aortic wall (Cook Inc. , Endologix Inc. , 
Medtronic Inc. , Vascutek Inc. , W L Gore Inc.). Apart from the actual diameter of the 
aneurysm neck the shape of the neck itself is also important. The aneurysm neck has 
been described in the literature as parallel, conical (tapered), flared (reverse tapered), 
barrel, irregular and hourglass shaped (McDonnell, Halak et al. 2006). Intuitively, the 
parallel configuration is the most amenable to providing a good proximal seal zone 
and the flared configuration the most unfavourable. A long, parallel proximal aortic 
neck is a favourable feature for EVAR planning. 
The recommended proximal aortic diameters that can be treated by endovascular 
means, range from 18 mm – 32 mm. To achieve an appropriate proximal seal between 
the endograft and the aortic wall, manufacturers recommend oversizing the proximal 
endograft by 10-20% to aortic neck diameter (Cook Inc. , Endologix Inc. , Medtronic 
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Inc. , Vascutek Inc. , W L Gore Inc.). There is some evidence to suggest that 
oversizing the proximal endograft by up to 25% reduces the incidence of proximal 
endoleaks, however with oversizing of >30% there is increased folding of the 
proximal aorta and also some evidence suggesting increased migration of the device 
(Sternbergh, Money et al. 2004, van Prehn, Schlosser et al. 2009, Lin, Kratzberg et al. 
2012). 
The angle of the aneurysm neck is an important consideration whilst planning. 
Angulation of the neck has an impact on the seal achieved and has also been linked to 
device migration. The two angulations to be considered are:  
1) Angle with the supra-renal aorta: this is the angulation between the supra-renal 
aorta and the immediate infra renal (neck) aorta. Manufacturers recommend 
that this angle should be less than 45°. (Angle ‘a’ Figure 1)  
2) Angle with long axis of the aneurysm: This is the angulation between the infra 
renal neck and the long axis of the aneurysm. General recommendations form 
the device manufacturers suggest a maximum limit of 60°. (Angle ‘b’ Figure 
1)  
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Figure 1: Schematic showing a typical infra-renal abdominal aortic aneurysm. Angle (a): angulation between 
supra-renal aorta and infra-renal ‘neck’, angle (b): angulation between infra-renal neck and long axis of the 
aneurysm, angle (c): maximum iliac angulation 
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Several authors have assessed the impact of thrombus burden and calcification in the 
proximal aortic neck and outcomes following endograft implantation (Chaikof, 
Fillinger et al. 2002, Walker, Kalva et al. 2010, Bastos Goncalves, Verhagen et al. 
2012). >50% circumferential calcification or thrombus (>2 mm thick) is regarded as 
an adverse feature for endovascular repair and has been associated with a higher 
incidence of inadequate proximal sealing.  
 
Iliac morphology 
Analogous to the proximal aortic neck, the iliac arteries provide the distal landing 
(sealing) zone for the endograft. The iliac vessels also provide access to the aneurysm 
for the endograft. Iliac vessel diameter, tortuosity and the presence of any stenosis 
will, therefore, have an impact on the procedure. The length and diameter of the iliac 
landing zone also influences the adequacy of distal sealing. The minimum 
recommended length of the iliac sealing zone varies between 10 – 15 mm for the 
commonly used devices (Cook Inc. , Endologix Inc. , Medtronic Inc. , Vascutek Inc. , 
W L Gore Inc.). Minimum iliac diameter required for the device to be able to pass 
through the iliac arteries is 7-8 mm. Iliac arterial diameters between 7 – 20 mm can be 
treated, larger or smaller arteries will require alternative sealing zones or other 
treatment modalities. As for the proximal neck, the device manufacturers recommend 
an oversize of 10 – 15 % (Cook Inc. , Endologix Inc. , Medtronic Inc. , Vascutek Inc. , 
W L Gore Inc.). To achieve adequate distal sealing, some patients would require the 
device to land in the external iliac arteries. In these cases, the internal iliac artery (if 
patent) can be embolised. However, it is important to try and keep at least one internal 
iliac artery in circulation (by deploying the iliac limb proximal to the internal iliac 
artery) to prevent complications such as bowel ischaemia and spinal cord ischaemia. 
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As discussed subsequently special iliac branch devices may be considered in selected 
cases. Increased tortuosity of the iliac arteries increases the technical difficulty 
associated with the procedure. Iliac tortuosity is measured as an index (τ); this is a 
ratio of the centre-line length to straight-line length from the aortic bifurcation to the 
common femoral artery. A (τ) of >1.6 or c (Iliac angle in schematic, maximum iliac 
angulation) < 90 are adverse features for endovascular repair (Chaikof, Fillinger et al. 
2002, Walker, Kalva et al. 2010).  
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Device types and characteristics 
 
EVAR grafts are composed of a metallic outer skeleton (stent) and a fabric graft. The 
metallic stent provides structural support to the device. Commonly used materials for 
these stents are nitinol (Nickel Titanium alloy) and stainless steel. The metallic 
exoskeleton scaffold encloses a fabric cylindrical or bifurcated trouser graft. These 
grafts are commonly made using expanded polytetraflouroehylene (ePTFE), 
fluorinated ethylene propylene (FEP) and polyester (polyethylene terephthalate, PET). 
The fabric of the device allows for exclusion of the aneurysm from the circulation. 
The principle of EVAR involves forming a proximal and distal seal with the aortic 
and iliac wall. The proximal seal with the aortic wall is achieved either by means of 
positive fixation (hooks or barbs that attach to the aortic wall) or by radial force. The 
distal seal is usually achieved by radial force.  
Devices attach to the aortic wall either at the supra or infra renal levels. EVAR 
devices utilising supra-renal fixation incorporate a short proximal bare metal stent 
(area devoid of fabric graft) that sits across the origins of the renal arteries. Devices 
with infra-renal fixation attach to the infra-renal aorta. Most devices tend to employ a 
combination of positive fixation with hooks or barbs and radial force (achieved by 
oversizing the graft by 15 – 20%).  
The supra-renal aortic wall is thought to be more resistant to post repair aneurysmal 
change. These devices are therefore thought to provide better fixation in cases with 
challenging or difficult anatomy (Robbins, Kritpracha et al. 2005). However, other 
reports have suggested that in the absence of other unfavourable features, patients 
with short neck lengths achieve similar results with both supra and infra renal fixation 
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(Hager, Cho et al. 2012). Deployment of bare metal stents used for supra-renal 
fixation across the origins of the renal arteries, also does not seem to have an impact 
on long-term renal function (Lau, Hakaim et al. 2003, Parmer, Carpenter et al. 2006). 
All EVAR devices have a modular design allowing for customisation based on the 
individual patients’ anatomy. There are three main types of devices  
1. Aorto-uni-iliac systems: These have stent-graft body that is deployed from the 
aorta into one common iliac artery. The contra lateral iliac artery (if patent) is 
usually occluded by means of an occluder device. This procedure is generally 
combined with the formation of a surgical femoro-femoral cross over graft to 
ensure blood flow into the contralateral leg. 
2. Bifurcated devices: These comprise a bifurcated main body with a ‘gate’ for 
docking of the contra-lateral iliac limb. Limb extensions are then placed as 
appropriate to customize the graft to the individual patient.  
3. Unibody endoprosthesis: These are positioned to sit on the aortic bifurcation. 
Modular pieces are then attached for proximal and distal extension.  
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Complex Endografts 
 
Approximately 20% of patients with abdominal aortic aneurysms will have 
unfavourable anatomical features for standard infra renal EVAR (Malina, Resch et al. 
2008). Endograft technology has evolved over the last decade such that branched and 
fenestrated endografts are now available for consideration of treatment in this patient 
group.  
Fenestrated EVAR 
	  
Figure 2: Fenestrated EVAR 
 
Fenestrated devices have special ports (“fenestrations”) built into the device through 
which visceral arteries can be cannulated and appropriate stents placed (bare metal or 
covered). These fenestrations in the graft material are reinforced with stent rings 
sutured to the graft material to provide strength to the device and prevent collapse of 
the visceral stent. The fenestrations usually come in three configurations: large 
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fenestrations, small fenestrations and scallops (incomplete fenestration at the end of 
the stent graft). The fenestrations allow for the entire stent graft to cover part of the 
supra-renal aorta without compromising the visceral arteries thereby enabling 
endovascular repair of juxta-renal aneurysms.   
 
Branched EVAR 	  
	  
Figure 3: Iliac branched EVAR © Cook Medical 
 
As for the fenestrated devices, branched EVAR devices have branches (small stent 
grafts) that are extensions from the main body of the device. These stent-graft 
branches are carefully manoeuvred into the visceral arteries during the procedure. 
Branched devices are particularly useful in cases where the aneurysm involves the 
Transcend: Preserve
Preserve flow to the int rnal iliacs.
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visceral vessels. Branched devices have also been used to treat aneurysmal iliac 
arteries where the aneurysms involve the origins of the internal iliac arteries. 
 
Chimneys and Periscopes 
 
Besides the techniques and newer grafts described above, standard grafts can be 
deployed alongside visceral stents, the proximal ends of which sit proximal (chimney 
technique) or distal (periscope technique) to the main endograft. The bodies of these 
visceral stents lie outside the main endograft body. This type of device placement is 
associated with a typical phenomenon called gutter endoleaks whereby blood tends to 
track alongside the visceral stents. 
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Complications 
 
EVAR is associated with potential complications, including graft migration, kinking 
and fracture, endoleaks and limb outflow impairment. These complications may 
necessitate further interventions to prevent mortality and morbidity through aneurysm 
rupture and distal ischaemia (Table 1). Thus, post EVAR patients undergo 
surveillance with serial scans to enable early detection of complications. 
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Table 1: EVAR complications table 
Immediate Early Late 
Deployment Failure  Endoleaks Device migration 
Incorrect device placement Endotension Device disruption 
Endograft kinking Endograft kinking Endograft kinking 
Aneurysm rupture Wound Infections Graft 
thrombosis/stenosis 
Conversion to open Device fracture Endoleaks 
Endoleaks Outflow compromise Infection 
Haemorrhage Visceral ischaemia  Aneurysm rupture 
Ischaemic complications 
(Legs, Spinal cord, Bowel, 
Kidneys) 
Renal impairment (incorrect 
device placement or contrast 
nephropathy) 
 
Mechanical obstruction, 
thrombosis, embolism 
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Endoleaks are defined as areas of persistent blood flow outside the graft, but within 
the aneurysm sac (Veith, Baum et al. 2002). Reports suggest that endoleaks can affect 
up to 20% of patients undergoing EVAR (EVAR trial participants 2005). They are 
thought to be responsible for most treatment failures beyond the first year.  Endoleaks 
have been classified into 5 types depending upon the origin of the leak (Table 2).  
Types I and III endoleaks are a result of inadequate seals at the proximal, distal 
sealing zones of the endograft and modular disruption respectively. These endoleaks 
typically have high flow rates with patients being at significant risk of continued sac 
pressurisation and subsequent rupture. Data from the EUROSTAR registry suggests 
that types I and III endoleaks are associated with a higher intervention rate compared 
to type II endoleaks. Patients with these types of endoleaks are also at significantly 
higher risk of aneurysm rupture compared to patients without endoleaks (van 
Marrewijk, Buth et al. 2002). Type II endoleaks are a result of back flow from patent 
inferior mesenteric or lumbar arteries. Compared to types I and III, they are typically 
slower, with recorded flow velocities at the origins of the endoleak vessels being in 
the range of 75 – 200 cm/sec (Arko, Filis et al. 2003).  
Arko et al (Arko, Filis et al. 2003) assessed whether intra-sac flow velocities could 
predict sealing of type II endoleaks. The followed up 265 patients that had been 
treated with the AneuRx® and Talent® (Medtronic Inc, AVE, Santa Rosa, California, 
USA) and found type II endoleaks in 23% patients at discharge. Spectral velocities 
were measured at the entrance of the feeding vessel at the sac. They found that 
patients with type II endoleaks that sealed spontaneously had velocities significantly 
lower than those in whom these endoleaks persisted. Persisting type II endoleaks had 
flow rates in excess of 100 cm/sec. The aneurysm sac diameter also responded to 
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sealing of endoleaks with sac diameters reducing after spontaneous sealing of 
endoleaks.  
Types I and III endoleaks usually require intervention, whereas type II endoleaks in 
the absence of associated increase in aneurysm sac size are usually managed 
conservatively. Re-intervention rates after EVAR have been reported to be as high as 
three to four times that of open repair (EVAR trial participants 2010).  
Table 2: Classification of endoleaks 
Endoleak Description (origin of flow) 
Type I 
A 
B 
C 
Attachment site leaks 
Proximal 
Distal 
Iliac Occluder 
Type II 
A 
B 
Branch Leaks 
Simple (1 patent branch) 
Complex (2 or more patent branches) 
Type III 
A 
B 
Graft defect 
Junctional leak or Modular defect 
Fabric Disruption (Midgraft Hole) 
Type IV Fabric Porosity (within 30 days of procedure) 
Type V 
A 
B 
C 
D 
Endotension 
With no endoleak 
With sealed endoleak 
With Type 1 or 3 endoleak 
With Type 2 endoleak 
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Type IV endoleaks are representative of porosity of the fabric of the endograft. By 
definition they occur within 30days of the procedure. The old Gore Excluder 
endoprosthesis® (W. L. Gore Inc., Newark, DE, USA) had specifically been 
associated with reduced shrinkage of the aneurysm sac after deployment compared to 
other devices (Bertges, Chow et al. 2003, Haider, Najjar et al. 2006). This was 
explained on the basis of porosity of the graft to serous fluid that moved across the 
expanded PTFE graft material. This device was substituted for a low permeability 
alternative in July 2004.  
Type V endoleaks are leaks that cannot be classified on imaging. Sub-classification is 
based on subsequent classification at open surgery.    
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Predictors of complications post EVAR 
 
Continued pressurisation of the aneurysm sac post endovascular repair usually results 
in enlargement of the sac size. Several studies have evaluated this enlargement with a 
view to identifying factors that would help predict such an outcome (Fairman, Nolte 
et al. 2006, Lalka, Greenberg et al. 2009, Schanzer, Greenberg et al. 2011). Fairman et 
al studied 351 patients who had undergone EVAR with the Zenith modular bifurcated 
device (Cook, Inc, Bloomington, Ind., USA). They identified presence of an endoleak 
and pre procedural aneurysm neck thrombus/calcification as factors predictive of sac 
size change. Their study population was selected for the Zenith AAA multicentre trial 
with favourable neck anatomy with only 6% of patients with circumferential neck 
thrombus/plaque. Despite their reported identification of the presence of neck 
thrombus and plaque the authors therefore argued that they had potentially 
underestimated the value of achieving an adequate proximal seal and its impact on 
subsequent complications. The authors also identified that all cases with sac 
enlargement were associated with the presence of an endoleak.  
Schanzer et al evaluated CT scans of 10228 patients who underwent EVAR in the 
United States between 1999 and 2008. Pre and post-operative scans were assessed to 
identify anatomical features that would be able to predict post endograft implantation 
abdominal aortic aneurysm sac enlargement. They also assessed these scans to 
ascertain the compliance with the device manufacturers’ instructions for use (IFU). 
They identified presence of an endoleak, age > 80 yrs., aortic neck diameter > 28 mm, 
aortic neck angle > 60 and common iliac artery diameter > 20 mm as independent 
predictors for AAA sac enlargement post EVAR (Table 3). Interestingly, they also 
found that only 42% of patients met the most conservative definition for IFU and 69% 
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the most liberal definition. The authors also identified that the rate of aneurysm sac 
expansion was significantly higher in patients who underwent EVAR outside of the 
device manufacturers IFU.  
Table 3: Predictors of sac enlargement (Schanzer, Greenberg et al. 2011) 
Predictors of AAA sac enlargement 
Age >80 
Conical aortic neck 
Aortic neck diameter > 28 mm 
Aortic neck angle > 60 
Common iliac artery diameter > 20 mm  
Anatomy outside IFU 
Presence of an endoleak during follow up 
 
One of the criticisms of this study by Schanzer et al has been the selection bias 
introduced by using the M2S database, which has been recognised to be non 
consecutive and may comprise selected and potentially more complex cases. No data 
was supplied to ascertain the time lapse between the baseline CT scan and EVAR; the 
enlargement in aneurysm sac size may have been pre-EVAR. Another point of not 
about this study was that the baseline AAA diameter for 59% of patients was <5.5 cm, 
the generally accepted size for intervention. M2S data included patient operated upon 
for reasons other than aneurysmal disease (aortic ulcer, iliac disease, pseudo 
aneurysms etc.) that may have confounded results. Schanzer et al utilised the pre 
procedural sac size rather than the immediate post procedural CT scans as their 
baseline AAA sac measurements that gain may have impacted upon the results. 
Nonetheless, the M2S database is a large database of patients that have undergone 
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endovascular repairs and is at least partly if not completely representative of changes 
that occur in the aneurysm sac post repair.   
These studies associating pre operative anatomy with the continued sac pressurisation 
illustrate the importance of adequate planning prior to undertaking endovascular 
interventions. Adherence to the instructions for use and judicious planning reduces the 
risk of developing complications such as endoleaks, device migration and late 
aneurysm ruptures that are associated with treatment failure.  
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Surveillance of patients post endovascular abdominal aortic aneurysm repair 
 
Post EVAR, patients routinely undergo imaging at regular intervals to detect 
complications. Computed tomography (CT) scanning has been widely regarded as the 
best current method for this surveillance (Veith, Baum et al. 2002). Duplex scanning 
has been proposed as an alternative to CT, but its use has not become commonplace 
due to the reported variation in its sensitivity and specificity in detecting these 
complications compared to CT (Wolf, Johnson et al. 2000, Raman, Missig-Carrol et al. 
2003, Elkouri, Panneton et al. 2004, Sandford, Bown et al. 2006).  
 
Currently available imaging options 
 
Computed Tomography (CT) 
 
CT angiography is widely regarded as the current modality of choice for surveillance 
of patients post EVAR. It has been demonstrated to be superior to conventional 
catheter angiography in detecting endoleaks (Armerding, Rubin et al. 2000). CT 
angiography delivers comprehensive vascular and non-vascular imaging and is 
convenient for patients due to its relatively quick scan acquisition time and 
widespread availability.  
Commonly employed CT surveillance protocols recommend regular scans at 3, 6 and 
12 months post implantation and at yearly intervals thereafter. CT surveillance scans 
have evolved from a single arterial phase protocol to biphasic (arterial and a delayed 
scan) and triphasic protocols (an initial non contrast scan followed by an arterial first 
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pass scan and a delayed scan). Traditionally, a triphasic protocol has been preferred 
for post EVAR surveillance. The non-contrast scan helps in the identification of high-
density materials. This enables differentiation between true endoleaks and areas of 
calcification or high attenuation that mimic endoleaks (pseudo-endoleaks) (Rozenblit, 
Patlas et al. 2003). The arterial first pass scan is followed by a delayed scan that aids 
in the detection of slow flow endoleaks which might have been missed on the first 
pass scan (Rozenblit, Patlas et al. 2003, Iezzi, Cotroneo et al. 2006).  
Following scan acquisition, the images are viewed on a CT workstation that has 
capabilities for multi-planar reconstruction (MPR). The entirety of the abdominal 
aorta is imaged, evaluating the proximal and distal sealing zones and comparing neck 
and iliac diameters with previous imaging. The aneurysm sac size is measured and the 
maximal size is compared to previous imaging. Areas of contrast enhancement 
outside of the stent-graft but within the aneurysm sac are investigated with a view to 
confirming endoleaks and ascertaining their origin. The integrity of the endograft is 
also evaluated and any impending complications commented upon.   
The prolonged nature of post EVAR surveillance subjects patients to a substantial 
radiation dose and has significant cost implications. The triphasic protocol (initial 
non-contrast scan, arterial first pass scan and delayed phase scan) exposes patients to 
a large radiation dose at every sitting. Some authors have suggested employing a 
biphasic protocol (unenhanced and arterial first pass scans), but others have argued 
about their reliability in detecting slow flow endoleaks (Golzarian, Dussaussois et al. 
1998, Rozenblit, Patlas et al. 2003, Iezzi, Cotroneo et al. 2006).  Some centres 
perform initial non-contrast scans only at the first scan opportunity. Subsequent scans 
are performed to a biphasic protocol, which are then compared with the initial non-
contrast scan, thus minimising radiation exposure to patients.  
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A standard triphasic post EVAR surveillance CT scan can expose patients to a 
radiation dose of approximately 20-30 milliseiverts (mSv), which is roughly 
equivalent to 300-400 plain X-rays. Such a dose has been associated with a theoretical 
lifetime risk of radiation induced fatal cancer in about 1 in 2000 patients (0.05%) 
(International Commission on Radiological Protection 2000). 
Contrast agents traditionally used for CT angiography comprise iodinated compounds 
that have been associated with an increased risk of anaphylaxis and nephropathy. 
Currently employed agents for post-EVAR CT angiography are organic (non-ionic), 
low osmolar compounds such as Iohexol (Omnipaque) and Ioversol (Optiray). These 
agents are more hydrophilic and less chemotoxic when compared to older contrast 
agents (McClennan 1987, McClennan 1990, Spring and Quesenberry 1991, Sovak 
1994, Dawson 1996, Cohan and Ellis 1997). 
CT contrast agents have been associated with anaphylactic reactions and are 
potentially nephrotoxic, thereby precluding their use in elderly patients with impaired 
renal function. A significant proportion of the patient population with abdominal 
aortic aneurysms is elderly and often present with mild to moderate impairment of 
renal function. These potential drawbacks have prompted investigators to explore 
other imaging modalities for surveillance of patients post EVAR.  
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Magnetic Resonance Angiography (MRA) 
 
MRA is an alternative imaging modality for EVAR surveillance and can provide 
imaging comparable, if not superior, to conventional CT scanning. A recent study, 
comparing the sensitivities of MRA and CT angiography for endoleak detection after 
EVAR, found MRA to be very sensitive in detecting slow flow endoleaks (van der 
Laan, Bartels et al. 2006). MR offers an advantage over CT scanning as it is free from 
radiation and does not employ iodinated contrast media. 
The scanning protocol commonly employed for MR scanning of this patient group, 
involves axial and/or coronal spin echo T1-weighted sequences and a contrast 
enhanced angiogram. Several synchronous phases are acquired beginning with the 
arterial phase and extending into the equilibrium and venous phases (Ayuso, de Caralt 
et al. 2004, Hellinger 2005, van der Laan, Bartels et al. 2006). This protocol 
maximises the chances of detecting complications. 
MR scanning, although reported to be very accurate in detecting slow flow endoleaks 
(van der Laan, Bartels et al. 2006), is associated with its own set of potential problems. 
Apart from the high costs involved, patients with stainless steel stent grafts are not 
suitable for MR scanning due to excessive artefact susceptibility. Cardiac pacemakers, 
intracranial aneurysm clips or any other ferromagnetic implants are contraindications 
for MR scanning. The images obtained with MR scanning also have a lower spatial 
resolution than CT and may less reliably detect calcification. MR scan acquisition 
also takes longer than for CT. Claustrophobic patients often require sedation prior to 
MR scanning. 
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Newer open MR scanners, provide weaker magnetic fields, and have not been 
preferred for post EVAR scanning. They provide less detailed imaging compared to 
standard tunnel scanners and have an even longer scan acquisition time. 
MRA employs organic gadolinium compounds as contrast agents. These agents utilise 
the inherent paramagnetic properties of gadolinium to alter magnetic fields around 
tissues. This alteration of magnetic fields provides for improved visualisation of 
vascular structures that helps in the detection of complications post EVAR. 
MR contrast agents, although considered to be safer than CT contrast agents in 
patients with mild renal impairment, have recently been found to be associated with 
Nephrogenic Systemic Fibrosis (NSF) in patients with severe renal impairment. 
Current MHRA (Medicines and Healthcare products regulatory Agency) guidance 
advises careful consideration prior to administering these contrast agents in patients 
with severe renal impairment (GFR [glomerular filtration rate] <30mL/min/1·73m2 or 
in patients who have had, or who are awaiting, liver transplantation) (Medicines and 
Healthcare products regulatory Agency 2007). 
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Duplex ultrasound (DUS) 
 
DUS has increasingly been used for surveillance of patients post EVAR. Widespread 
availability and relatively low cost association of DUS have made it popular with 
researchers. Yet, its use has not become commonplace. This has been attributed to a 
lack of universal reproducibility of highly specific and sensitive results in detecting 
complications post EVAR (Wolf, Johnson et al. 2000, Raman, Missig-Carrol et al. 
2003, Elkouri, Panneton et al. 2004, Sandford, Bown et al. 2006). Its operator 
dependent nature, difficulties in visualising abdominal viscera in patients of large 
body habitus and bowel gas interference have all been thought to be responsible for 
this variation. 
For a standard post EVAR surveillance duplex, the aorta is scanned in both 
longitudinal and transverse planes using B-mode imaging to determine the extent of 
the stent-graft and to ascertain the maximum aortic sac diameter. Colour Doppler is 
then used to scan the aorta from the diaphragm or origin of renal arteries down to the 
common femoral arteries, evaluating the stent for integrity and kinking. Special 
attention is paid to the proximal and distal stent-graft attachment sites and to the 
origin of the inferior mesenteric and lumbar arteries to detect endoleaks. 
Vastly improved endoleak detection rates have been reported by some recent studies 
employing contrast-enhanced ultrasound (Bendick, Bove et al. 2003, Giannoni, 
Palombo et al. 2003, Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006). 
Second generation contrast agents, preferred nowadays, including Sulphur 
Hexafluoride (Sonovue) and Galactose / Palmitic Acid (Levovist) are gas-filled, 
stable micro bubbles that have a high degree of echogenicity. These micro-bubbles 
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cause an increase in backscatter, which is detected by ultrasound, and aids in the 
identification of endoleaks. 
These results, although encouraging, have not been uniform (McWilliams, Martin et 
al. 1999, McWilliams, Martin et al. 2002, Bendick, Bove et al. 2003, Giannoni, 
Palombo et al. 2003, Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006). In 
1999, a study conducted by McWilliams et al, comparing contrast enhanced duplex 
with arterial phase CT found duplex to be very sensitive and specific and questioned 
whether endoleaks identified by duplex and missed by CT were not, in fact, true 
endoleaks (McWilliams, Martin et al. 1999). A further study by the same group 
published in 2002, this time comparing contrast enhanced duplex with biphasic CT 
could not reproduce the same results and found CT to be a better tool (McWilliams, 
Martin et al. 2002). Henao et al, using a continuous infusion technique and comparing 
contrast-enhanced duplex to biphasic CT, found duplex to be comparable to CT and 
suggested its use as a primary surveillance modality (Henao, Hodge et al. 2006). 
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Intra-sac pressure monitoring 
 
EVAR diverts blood flow through the stent graft, excluding the aneurysm from the 
circulation. This process is intended to prevent an increase in the intra sac pressure of 
the aneurysm. Endoleaks, especially types I and III are associated with an increase in 
sac pressures that can cause ruptures. There has been substantial interest in measuring 
intra-sac pressure as a means to carry out surveillance of patients post EVAR. Intra-
sac pressures can be monitored either by using an implanted monitoring device or by 
performing a puncture of the aneurysm sac. Several implantable pressure monitoring 
devices have been trialled: 
1. The Impressure AAA sac pressure sensor (Remon Medical Technologies, 
Caesarea, Israel). This system is ultrasound activated and communicates using 
ultrasound waves with an external monitor to provide pressure monitoring. On 
demand sac pressures can be obtained in an office setting. 
2. The CardioMEMS Endosure wireless AAA pressure sensor (CardioMems, 
Atlanta, GA) uses radiofrequency (RF) to transmit pressure readings to an 
external module. 
3. The TPS Telemetric pressure sensor (Helmholtz institute for biomedical 
engineering, RWTH, Aachen, Germany) uses a telemetric digital sensor and 
transmits data to an external monitoring station. 
Direct measurement of sac pressures: The aneurysm sac can be punctured with guide 
wires mounted with pressure sensors to monitor intra-sac pressures. Several 
approaches have been described including translumbar sac puncture and transvenous 
transcaval puncture.  
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Aneurysm sac pressures tend to reduce following successful EVAR (Chuter, Ivancev 
et al. 1997, Sonesson, Dias et al. 2003, Dias, Ivancev et al. 2004). Types I and III 
endoleaks are associated with increased sac pressures. The APEX trial (Ohki, Ouriel 
et al. 2007) used a > 30% reduction in pulse pressure from the initial pressure to 
define a sealed sac and < 30% reduction to indicate a type I or III leak. However, type 
II endoleaks remain a diagnostic challenge as in cases of these endoleaks sac 
pressures may increase, decrease or remain the same. Sac pressures depend on the 
specific configurations of inflow and outflow channels; hence complex type II leaks 
are associated with variable pressure changes.  
Authors continue to debate the clinical relevance of intra sac pressure measurements. 
Measuring sac pressures offers a physiological means of assessing the risk of rupture 
but it does not, currently, obviate the requirement for imaging. Further, sac pressure 
measurement depends upon the exact location of the measurement position within the 
sac. It has been demonstrated that pressures are higher within the endoleak channel as 
compared to elsewhere within the aneurysm sac (Dias, Ivancev et al. 2007). The 
dampening effect of thrombus may also affect pressure transmission. Concerns 
remain regarding this phenomenon that has been described as ‘compartmentalisation’ 
and the effects that this might have on the accuracy of intra-sac pressure monitoring. 
The consensus therefore remains that although intra-sac pressure monitoring remains 
a valuable adjunct to post EVAR surveillance, there is not enough evidence at present 
for it to be the sole surveillance modality. 
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Surveillance Costs 
 
Patients post endovascular aneurysm repair need lifelong surveillance to detect 
associated complications. Current surveillance protocols employing regular CT scans 
have implied a high cost association with EVAR. Typical post EVAR CT and MR 
scans cost approximately £750-1000 ($1500 – 2000)* and £1000 – 1300 ($ 2000 – 
2600)* respectively. Typical post EVAR surveillance duplex, in comparison, cost 
approximately £300 - 400 ($600 - 800)* (*Indicative costs referenced from 2 
independent UK hospitals at the time of the original research, likely to have reduced 
over the years).  Surveillance costs for both these modalities are likely to become 
cheaper with widespread use of both CT and DUS. 
Surveillance programmes need to be both clinically sound and cost effective. Post 
EVAR surveillance has traditionally been carried out with regular CT scans that have 
been responsible for the high costs associated with it. A clinically proven surveillance 
programme incorporating duplex ultrasound would offset some of these costs. 
The ideal imaging modality for surveillance of patients post EVAR, would be 
inexpensive, widely available, provide universally reproducible results and subject 
patients to little or no radiation.   
Every imaging modality used for this surveillance, has been associated with its own 
set of advantages and disadvantages. DUS is inexpensive, does not use iodinated 
contrast media and is relatively easy to perform. These advantages would make 
duplex the ideal surveillance modality but for its reliability in producing highly 
sensitive and specific results, which remains to be proven. 
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Ultrasound phantoms 
 
Ultrasound phantoms are specially designed objects that when scanned provide 
consistent results similar to scanning human tissue. They contain one or more 
materials that simulate the interaction of tissues with ultrasound and have traditionally 
been used to provide quality assurance and as simple calibration tools for imaging 
modalities. However they are now also being increasingly employed for the provision 
of medical training by simulating anatomic and acoustic representations of events that 
occur within the human body.  
Ultrasound phantoms can now be used to simulate conditions and events as diverse as 
abdominal aortic aneurysms to foetal development. Current applications for 
ultrasound phantoms include quality assurance of ultrasound systems, training for 
performing ultrasound guided biopsies, foetal developmental monitoring; and 
aneurysm surveillance and detection.  
Phantoms are constructed using materials that mimic the ultrasonic characteristics of 
human tissue or tissue mimicking materials (TMM), and usually contain a target or 
test object. The entire structure is housed within a casing, which prevents damage to 
the TMM by handling and desiccation. This casing could vary from being a simple 
film to an entire housing frame with windows that allow for transmission and 
reception of ultrasound waves.    
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Tissue mimicking materials 
 
Tissue mimicking materials simulate the acoustic properties (i.e. speed of sound, 
attenuation coefficient, backscatter coefficient, elasticity and thermal properties) of 
human soft tissue. These properties of the TMM are either known or are established 
as a standard prior to the phantom being employed (Teirlinck, Bezemer et al. 1998, 
Madsen, Dong et al. 1999, Ramnarine, Anderson et al. 2001). TMMs could be a slab 
of homogenous tissue or may contain other objects with known shape, size, depth and 
ultrasonic parameters.  
Commonly employed tissue mimicking materials include agar, urethanes, epoxies and 
other natural materials such as vegetable oil. Table 8 provides the physical properties 
of the tissue mimicking material that was used as part of our study. 
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Blood mimicking materials 
 
Blood mimicking fluids used in ultrasound phantoms mimic the acoustic and 
hemodynamic properties of blood. Typically these materials consist of particles 
suspended in a fluid. Historically particles such as sephadex, starch, nylon, 
polystyrene microspheres and hardened red blood cells have been used. For a solution 
to be employed as a blood mimic, its physical and ultrasonic properties should be 
similar to human blood (Ramnarine, Nassiri et al. 1998). Specifically, the suspended 
particulates should be of a similar size, shape to red blood cells and should remain 
buoyant even at low velocities. The ultrasound backscatter of the fluid should also be 
comparable to that of flowing human blood. Table 9 provides the physical properties 
of the blood mimicking fluid employed for our study. 
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DUS and CT for post EVAR surveillance: Literature review 
 
A literature review was performed to identify the existing knowledge base regarding 
surveillance of patients post EVAR, comparing Duplex ultrasound and CT. 
MEDLINE and Embase databases were searched using medical subject headings 
(MeSH terms) (Table 4) with the Boolean operatives AND or OR. Additional studies 
were included through review of abstracts presented at various vascular surgical 
conferences. 
Table 4: MeSH terms used for literature review 
MeSH terms 
Aortic aneurysm 
Blood vessel prosthesis 
Implantation 
Stents 
Endovascular procedures 
Surveillance 
Doppler ultrasound imaging 
Ultrasonography 
Angiography 
Computed tomography 
Contrast media 
 
The search included all papers published between 1996 and 2006. Abstracts for all 
studies were reviewed. Twenty-one studies published in English were identified that 
directly compared CT and DUS for surveillance of patients post endovascular 
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aneurysm repair; these formed the basis for our literature review (Table 5). Inclusion 
criteria were defined as provision of adequate patient data, assessment of concurrent 
CT and either DUS or contrast-enhanced DUS scans, publication in English language 
journals and availability of full text for review. Primary outcome measures were 
defined as the sensitivity and specificity of Duplex ultrasound for the detection of 
endoleaks.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Full text articles assessed for eligibility n=24 	  
Studies remaining after removal of duplicates 
and foreign language studies n=175 	  
Additional studies included through 
alternative sources n=5 	  
Studies with full text articles available and 
meeting inclusion criteria (studies used for 
analysis) n= 21 
Studies identified on database search 
n=363	  
Studies excluded n=151 	  
Full text articles 
excluded n=3  
Insufficient data n=2 
Examinations not 
performed concurrently 
n=1 
Figure 4: PRISMA flowchart for literature review 
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Table 5: Studies included in review of literature comparing CT and DUS for post EVAR surveillance 
Study Year 
Heilberger et al (Heilberger, Schunn et al. 1997) 1997 
Sato et al (Sato, Goff et al. 1998) 1998 
Thompson et al (Thompson, Boyle et al. 1998) 1998 
McWilliams et al (McWilliams, Martin et al. 1999) 1999 
Wolf et al (Wolf, Johnson et al. 2000) 2000 
Zannetti et al (Zannetti, De Rango et al. 2000) 2000 
d’Audiffret et al (d'Audiffret, Desgranges et al. 
2001) 
2001 
Pages et al (Pages, Favre et al. 2001) 2001 
Golzarian et al (Golzarian, Murgo et al. 2002) 2002 
Greenfield et al (Greenfield, Halpern et al. 2002) 2002 
McWilliams et al (McWilliams, Martin et al. 2002) 2002 
Parent et al (Parent, Meier et al. 2002) 2002 
McLafferty et al (McLafferty, McCrary et al. 2002) 2002 
Bendick et al (Bendick, Bove et al. 2003) 2003 
Raman et al (Raman, Missig-Carrol et al. 2003) 2003 
Giannoni et al (Giannoni, Palombo et al. 2003) 2003 
Napoli et al (Napoli, Bargellini et al. 2004) 2004 
Elkouri et al (Elkouri, Panneton et al. 2004) 2004 
AbuRahma(AbuRahma, Welch et al. 2005) 2005 
Sandford et al (Sandford, Bown et al. 2006) 2006 
Henao et al (Henao, Hodge et al. 2006) 2006 
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Endovascular abdominal aortic aneurysm repair necessitates serial follow up of 
patients to diagnose complications that could lead to potentially life threatening 
events such as aneurysm rupture. Typical surveillance protocols have been based on 
regular CT scanning post EVAR. Several researchers have attempted to devise a 
surveillance protocol for these patients based on Duplex ultrasonography with 
variable success Table 5. 
 
Protocols for imaging and surveillance 
 
Patients post EVAR are usually maintained in a registry and undergo regular 
surveillance scans usually with CT. Studies evaluating alternative imaging modalities 
have involved concurrent or paired imaging alongside regular CT scans. Most studies 
included in this literature review comparing DUS and CT for EVAR surveillance have 
analysed paired or concurrent DUS and CT examinations for patients (Wolf, Johnson 
et al. 2000, Zannetti, De Rango et al. 2000, Raman, Missig-Carrol et al. 2003, 
Sandford, Bown et al. 2006). These paired examinations have been performed within 
a specified time interval of each other to prevent inaccuracies in the study due to a 
time lag between the two imaging modalities. Surveillance protocols have involved 
scanning at 1 month, 3 months, 6 months, 1 year and at annual intervals thereafter 
unless complications were detected when departures have been made from the 
established protocol. 
 
The protocol for CT examinations used for these studies has varied between using 
single phase CT scans (arterial phase scan) to complete triphasic scans (initial non 
contrast scan, arterial phase scan and delayed phase scan). Some studies have 
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employed a single arterial phase scan for EVAR surveillance to limit radiation 
exposure for these patients. The initial non-contrast scan performed prior to EVAR 
deployment was used as baseline for identifying calcification at subsequent scans. A 
delayed phase scan was performed only when a slow endoleak was suspected. 
Intravenous contrast was injected using a pump injector at a rate of 2.5 ml/s. The 
standard delay for the arterial phase was 28 sec and 60 sec after completion of the 
arterial scan for the delayed phase. The scanning parameters were similar for the 
studies utilising 5 mm collimation, 0.5 – 1 sec tube rotation, pitch of 2 and 
reconstruction every 3-5 mm. 
 
The DUS protocol similarly remains largely uniform throughout these studies. A 2.0 
to 3.5 MHz abdominal probe was used for the examination. Scanning began with 
identifying the limits of the stent graft in B-mode and assessment of its integrity, 
imaging the aorta from the coeliac artery origin down to the iliac bifurcation. Flow 
was confirmed within the aorta and iliac vessels and peak velocities compared to 
diagnose limb stenosis or kinking. The proximal and distal stent attachment sites were 
imaged, as were the origins of the inferior mesenteric, lumbar and renal arteries. Any 
flow seen in the peri-graft area was assessed closely to identify and classify endoleaks. 
Some researchers asked patients to be on a low residue diet the day before their scan, 
and to fast on the day of the scan to minimise bowel gas interference with scanning. 
For contrast-enhanced ultrasound, the agents used were Levovist and Optison, with 
either slow injection of the contrast agent through the ante-cubital fossa or through 
continuous infusion (Henao, Hodge et al. 2006). 
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Helberger et al (Heilberger, Schunn et al. 1997) were amongst the first to report the 
routine use of duplex ultrasonography for surveillance of patients post endovascular 
repair.  They employed contrast-enhanced ultrasound using Levovist as the contrast 
agent for duplex. Although they did not report on the sensitivity and specificity of 
DUS compared to CT, they suggest that contrast-enhanced duplex was equivalent to 
CT in detecting major endoleaks and in fact was more sensitive in detecting slow flow 
type II endoleaks. 
Duplex ultrasound 
 
Sato et al (Sato, Goff et al. 1998) defined adequacy of duplex scans by four criteria, 
namely: 
1. Satisfactory B-mode imaging of the AAA sac and the stent graft 
2. Satisfactory colour Doppler imaging with no excessive overgain or undergain 
3. Satisfactory colour Doppler assessment of the entire AAA sac in both 
longitudinal and transverse planes to screen for endoleaks 
4. Spectral Doppler waveform confirmation of potential endoleaks 
They retrospectively reviewed records from 117 concurrent CT and DUS 
examinations in 79 patients who had undergone EVAR. Despite reporting only 19% 
of their DUS scans to be adequate according to the above criteria, they found high 
sensitivity and negative predictive value for DUS (97% & 98% respectively) in 
diagnosing the presence of an endoleak post EVAR. They attributed their low 
specificity and positive predictive value (74% and 66% respectively) to the absence of 
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a standardised DUS protocol as their scans had been performed on patients across 
multiple sites using multiple DUS operators.  
When comparing DUS and CT for detection and characterisation of endoleaks, Wolf 
et al (Wolf, Johnson et al. 2000) and Zannetti et al (Zannetti, De Rango et al. 2000), 
reported encouraging results for DUS. Specifically they have reported high specificity 
(95% and 98.4% respectively) and negative predictive values (90% and 99.4% 
respectively). Zannetti et al report good sensitivity for DUS (91.7%) in detecting the 
presence of endoleaks; however, when determining the source of the endoleak, this 
sensitivity drops to 66%. In their series, DUS failed to correctly classify two 
endoleaks as type 1, diagnosing them to be type 2 instead and failed to diagnose one 
endoleak seen on CT. They therefore conclude that although DUS could reduce the 
requirements for CT scanning, it could not completely replace CT for post EVAR 
surveillance. Wolf et al, however, report excellent results and conclude that DUS in 
experienced hands could provide results that are very similar to CT in detecting and 
classifying endoleaks. Their graft patency detection rates and aneurysm size 
measurements were also very similar for both modalities. They report that all 
endoleaks that DUS missed in their study were small, posterior endoleaks (Type 2 
lumbar) and suggest that all leaks diagnosed on DUS and missed on CT were in fact 
true endoleaks associated with to-and-fro flow in the inferior mesenteric artery. They 
claim that both these classes of leaks were probably not clinically significant and 
suggest that DUS may be used for routine surveillance and follow up of patients post 
EVAR.  
This theme is reproduced throughout the literature for proponents of DUS. Detractors, 
however point to the poor sensitivity and positive predictive value of DUS. Raman et 
al (Raman, Missig-Carrol et al. 2003) carried out retrospective reviews of 495 same-
	   71	  
day CT and DUS scans performed post EVAR and reported DUS to be 42.9% 
sensitive with a positive predictive value of 53.9% for detection of endoleaks. They 
suggest that these results could be attributable to being able to devote less time for 
individual DUS scans. They argue that as opposed to other studies reporting good 
results for DUS, they could only allocate approximately 20 minutes per scan and used 
older equipment and as such these technical factors might have had an impact on their 
results.  
McLafferty et al (McLafferty, McCrary et al. 2002) have reported excellent endoleak 
detection rates (100% sensitivity, 99% specificity, 88% positive predictive value and 
100% negative predictive value) for DUS as compared to CT, however, it has to be 
remembered that their methodology was different as compared to other series. As part 
of their on-going phase II and III trials evaluating the AneuRx stent graft, they carried 
out DUS surveillance one-month post stent graft placement. Their protocol did not 
include paired/concurrent CT and DUS scans; the DUS scan 1-month post EVAR was 
followed by a CT scan at 3 months if the DUS was positive for an endoleak, or a CT 
scan at 6 months if the DUS was negative for an endoleak. The sensitivity, specificity, 
positive and negative predictive values of DUS were calculated comparing DUS 
results at 1 month to the CT results at 3 or 6 months.  
Contrast enhanced DUS 
 
Several authors have evaluated contrast enhanced DUS as a modality of surveillance 
of patients post endovascular aneurysm repair (Heilberger, Schunn et al. 1997, 
McWilliams, Martin et al. 1999, McWilliams, Martin et al. 2002, Giannoni, Palombo 
et al. 2003, Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006).  Heilberger et al 
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were among the first to employ contrast enhanced duplex for post EVAR surveillance. 
They used Levovist (D-Galactose and Palmitic acid) as an ultrasound contrast agent. 
As described previously, ultrasound contrast agents are made up of stable 
microbubbles that can be detected on ultrasound. Heilberger et al have reported 
excellent results with unenhanced DUS, detecting all major endoleaks except one that 
was thought to have been missed due to the presence of excessive bowel gas. 
Employing contrast enhanced DUS, they detected endoleaks that were not seen on 
either CT or catheter based angiography. As they did not consider CT to be their gold 
standard imaging modality, they argue that these leaks represent true endoleaks, thus 
reporting contrast enhanced DUS to be better at detecting endoleaks post EVAR. 
However, their results revealed that DUS was not as good as CT when evaluating 
graft integrity. 
Using the same ultrasound contrast as Heilberger et al, McWilliams et al 
(McWilliams, Martin et al. 1999) performed a pilot study evaluating contrast 
enhanced DUS on 18 patients who also underwent single phase CT scans on the same 
day as the DUS. They found an increase in the sensitivity of duplex with the 
introduction of contrast, being able to diagnose all endoleaks visualised on CT. 
Further, they also diagnosed 6 false positive leaks on contrast-enhanced duplex, some 
of which were associated with an increase in the aneurysm sac size. They argued that 
these could in fact represent true endoleaks that were not visualised on single phase 
CT.  A follow on study by the same group published in 2002 (McWilliams, Martin et 
al. 2002), compared unenhanced and contrast-enhanced duplex with biphasic CT. 
However, having followed up 53 patients with 96 scans, they could not replicate their 
earlier results. Although they reported the sensitivity of DUS to improve to 50% with 
the introduction of contrast (12% for unenhanced DUS), contrast enhanced ultrasound 
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missed 9 type 2 endoleaks in their series. They also reported 2 graft related leaks 
(types I or III), only one of these was diagnosed on ultrasound. The number of false 
positive endoleaks also increased with the introduction of ultrasound contrast; 
increasing from 4 on non-contrast DUS to 19 on contrast enhanced DUS. 
Encouraging results were published by Giannoni et al (Giannoni, Palombo et al. 2003) 
employing Levovist for contrast-enhanced ultrasound. They found the sensitivity of 
DUS to improve to 100% with the introduction of ultrasound contrast. However, they 
too report a large number of false positives whilst detecting endoleaks. The 
overestimation of endoleaks with the introduction of ultrasound contrast is presumed 
to be a result of blooming of colour when the contrast agent reaches the site of 
investigation.  
Contrast enhanced DUS using a second generation ultrasound contrast agent 
(Sonovue) was employed to further screen a group of 10 patients who were found to 
have enlargement of their post EVAR aneurysm sacs in the absence of endoleaks on 
CT and DUS by Napoli et al (Napoli, Bargellini et al. 2004). Contrast enhanced DUS 
detected endoleaks in all of these patients and these were confirmed in 8 patients on 
catheter angiography. The remaining 2 patients had unclassified leaks that were again 
confirmed on delayed CT. Napoli et al also subjected a further 20 patients to contrast 
enhanced DUS, 10 of whom had evidence of aneurysm shrinkage with no 
demonstrable endoleaks on either CT or DUS and a further 10 who had evidence of 
type 2 endoleaks on CT and DUS. These groups acted as controls for their study. 
Napoli et al employed low mechanical index 0.01-0.04 and real time tissue harmonic 
imaging for enhanced duplex ultrasound. These enhancements might explain their 
superior results.  
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Henao et al (Henao, Hodge et al. 2006) have again reported excellent endoleak 
detection rates with contrast enhanced ultrasound, albeit with a slightly different 
methodology. They used a second-generation ultrasound contrast media (Optison – 
Octafluoropropane and albumin) with a continuous infusion technique. Their DUS 
protocol was also modified to include harmonic imaging, reduced mechanical index 
of 0.4-0.5, compression of 1:3 and a focal zone positioned below the aorta to 
minimize microsphere rupture. They claim that these measures allowed for a longer 
scanning time. Though these measures have probably been responsible for their 
excellent results, their study also detected an additional 3 type 2 endoleaks that were 
not visualised on CT; these could be termed false positives when using CT as the gold 
standard.  
DUS has been traditionally used for carrying out surveillance of patients known to 
have abdominal aortic aneurysms. Even though frequently used for this surveillance it 
has been acknowledged that DUS underestimates the size of abdominal aortic 
aneurysms as compared to CT (Lederle, Wilson et al. 1995). Specifically comparing 
these two modalities for estimation of AAA sac size post EVAR, there seems to be 
good correlation but poor agreement.  
The general consensus therefore remains that DUS, although not at a stage to 
completely replace CT, can be a useful tool to reduce the number of CT scans that 
these patients have to undergo. The diagnostic accuracy of DUS does seem to increase 
with the introduction of contrast media; however, there is also a corresponding 
increase in the number of false positive endoleaks. 
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Conclusions 
 
The common theme throughout most of these studies was that although Duplex is a 
relatively cheap imaging modality, its sensitivity in detecting complications in the 
post EVAR setting was low when compared to the gold-standard CT imaging. The 
specificity however was good as was its negative predictive value. The consensus 
view therefore was that Duplex remains an adjunct to CT for post EVAR surveillance. 
Its sensitivity in this patient group does not support its use a sole imaging modality.	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Aims of the study 
 
Our study has been designed to assess the existing limitations of duplex ultrasound for 
the surveillance of patients post endovascular repair of their abdominal aortic 
aneurysms. We propose to assess these limitations through the clinical arm of our 
study. We have introduced a surveillance protocol whereby patients post endovascular 
repair would undergo paired CT and DUS that would ideally be performed on the 
same day. CT scans would be reported by a team of vascular radiologists who would 
be blinded to the results of the Duplex scans. Similarly, a dedicated vascular 
laboratory with operators who have experience in ultrasonography of the post EVAR 
aorta would perform the Duplex scans. Similar to the vascular radiologists, the 
ultrasound operators would be blinded to the CT results. 
In parallel, we have set up the laboratory experiment to ascertain the machine, 
operator dependant and independent characteristics of Duplex ultrasound that impact 
upon detection of complications in this setting. We propose to achieve this through 
the development and analysis of a non-anthropomorphic ultrasound phantom using 
novel tissue and blood mimicking materials to reproduce the acoustic events of the 
human aorta post endograft implantation. If successful, we would be able to ascertain 
whether the machine dependant parameters can be changed to improve the sensitivity 
of Duplex ultrasound to a level that would enable its use a sole surveillance modality 
for patients post EVAR. 
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Study design 	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EVAR has become an integral part of treatment protocols for abdominal aortic 
aneurysms, with many vascular surgical units across the UK now offering this 
minimally invasive approach for repair of abdominal aortic aneurysms. However, 
surveillance for patients post EVAR remains an important consideration. There has 
been a lack of consensus amongst vascular specialists for a standardised protocol for 
post EVAR surveillance and debate persists regarding the most appropriate imaging 
modality to carry out this surveillance (Heilberger, Schunn et al. 1997, Sato, Goff et 
al. 1998, McWilliams, Martin et al. 1999, Wolf, Johnson et al. 2000, Zannetti, De 
Rango et al. 2000, d'Audiffret, Desgranges et al. 2001, McWilliams, Martin et al. 
2002, Giannoni, Palombo et al. 2003, Raman, Missig-Carrol et al. 2003, Elkouri, 
Panneton et al. 2004, Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006, 
Sandford, Bown et al. 2006). 
Our study was designed to assess whether routine surveillance for patients post 
EVAR could be performed with Duplex ultrasound. CT based surveillance protocols 
have traditionally been favoured, CT scanning being regarded as gold standard 
imaging in major studies comparing different modalities (Heilberger, Schunn et al. 
1997, Sato, Goff et al. 1998, McWilliams, Martin et al. 1999, Wolf, Johnson et al. 
2000, Zannetti, De Rango et al. 2000, d'Audiffret, Desgranges et al. 2001, 
McWilliams, Martin et al. 2002, Giannoni, Palombo et al. 2003, Raman, Missig-
Carrol et al. 2003, Elkouri, Panneton et al. 2004, Napoli, Bargellini et al. 2004, Henao, 
Hodge et al. 2006, Sandford, Bown et al. 2006). A significant proportion of post 
EVAR surveillance in the UK, including at our centre, has been dependant solely on 
CT scanning.  
Our study was divided into a clinical and a laboratory arm. For the clinical part of our 
study, we organised for patients post EVAR who were previously being followed up 
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with regular CT scans, to have an additional DUS scan to be performed within a 
specified time period of the CT. For the laboratory part of the study, we designed a 
non-anthropomorphic ultrasound phantom that allowed us to assess the sensitivity of 
DUS when scanning patients post endovascular repair of their infra-renal abdominal 
aortic aneurysms. The aim of our study was to assess the sensitivity and specificity of 
DUS for the identification of endoleaks in the post EVAR setting as it currently 
stands and to ascertain the possibility of improving this through our non-
anthropomorphic ultrasound phantom.   
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The laboratory arm
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The laboratory arm of this project was designed to assess the limitations of Duplex 
ultrasound as a surveillance modality in the post EVAR setting. A novel ultrasound 
phantom was designed using tissue and blood-mimicking materials to simulate 
aspects of the blood flows and associated geometry of the abdominal aorta post 
endovascular aneurysm repair. The phantom was not an anthropomorphic depiction of 
the post EVAR aorta but enabled the evaluation of the key parameters of 
complications post EVAR. It also allowed for experimental control of the principal 
variables affecting ultrasonic imaging and measurement of the simulated blood flow 
of the post EVAR aorta. Also, the geometry of the phantom was such that key 
features determining the sensitivity of the ultrasound scanner could be assessed. A test 
protocol was formulated and various experimental set ups were evaluated by 
operators with varying levels of experience in vascular ultrasound.  
Results were analysed to determine the limitations of duplex in detecting 
complications post EVAR. Inter-observer variations were analysed to determine the 
level of expertise required for accurate detection and classification of complications.   
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Phantom design 
 
Endovascular repair of abdominal aortic aneurysms involves the placement of a stent-
graft across the aneurysm from within the circulation. As discussed previously, major 
complications post EVAR include endoleaks, which have been thought to be 
responsible for most treatment failures beyond the first year. Endoleaks have been 
classified into 5 types depending upon their origin (Table 2). High flow and persistent 
low flow endoleaks can lead to continued pressurisation of the aneurysm sac that can 
result in its rupture. This and other potential complications such as graft fracture and 
migration have necessitated life long follow up of patients.  
With ultrasound scanning, all endoleaks whether graft related or a result of back flow 
from the origins of other arteries within the aneurysm sac are visualised as flow 
separate from the aortic flow but within the aneurysm sac. This was used as the 
central theme when conceptualising the design of the phantom. The phantom 
consisted of a Perspex® (Lucite International, Memphis, Tennessee, USA) casing 
housing tissue mimicking material (TMM) i.e. the material has ultrasonic properties 
equivalent to human tissue. A stent-graft was placed centrally within the TMM and 
this simulated the ultrasound appearance of the abdominal aorta post EVAR. Flow 
channelled through this stent-graft depicted flow of blood through the aorta post 
endovascular repair. A second flow system, comprising of tubing of a significantly 
smaller diameter than the stent-graft, was used to simulate an endoleak. This second 
flow system ran obliquely along the length of the phantom and crossed the aortic 
stent-graft at its midpoint. Thus, the geometry of the smaller diameter flow system 
relative to the larger aortic flow allowed the opportunity to visualise their spatial 
relationships from different perspectives (Figure 5). This enabled the small flow to be 
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effectively ‘moved’ and hence be proximal or distal to the larger flow. A number of 
different endoleak scenarios could thus be repeatedly investigated.   
Blood-mimicking fluid (BMF), that simulated the ultrasound properties of blood, was 
circulated in both the small ‘endoleak’ and large ‘aortic’ flow circuits. The flow rates 
in the two flow systems were different; BMF was pumped through the larger stent 
graft to simulate the appearance and flow characteristics of blood flowing through the 
abdominal aorta. BMF flow rates through the smaller endoleak flow were designed to 
simulate the typical range of clinical leaks and could be adjusted as an independent 
variable for each experiment. 
The entire phantom could also be rotated along the axis of the large flow to enable the 
ultrasound operator to view the phantom from all sides. This arrangement gave a 
different view of the endoleak and the stent graft from each side of the phantom 
(Figures 1 & 2) 
A test protocol evaluating various configurations of the geometrical and flow 
parameters was designed and used to evaluate the phantom by operators with varying 
levels of experience in vascular ultrasound.   
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Figure 5: Schematic depicting the geometrical relationships of the small and large flows. (a) Tangential, (b) 
Proximal and (c) Distal planes. (For the purposes of depiction the small and large flow systems are some 
distance apart even though in the phantom they are exactly adjacent to each other at the point they cross each 
other.)
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Figure 6: Schematic depicting the arrangements of the large (shaded) and small flow systems (unshaded) 
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The Phantom 
 
A custom-made 162 x 200 cm cuboidal Perspex box was used to house the ultrasound 
phantom. Perspex (methyl methacrylate) is a strong, lightweight acrylic material that 
has good impact strength and high environmental stability. A 24 mm inner diameter 
Medtronic Talent® (Medtronic Inc., Minneapolis, Minnesota, USA) aorto-uni-iliac 
stent graft was placed centrally within the Perspex box (Figure 7). When connected to 
the aortic flow, the ultrasonic appearance of this stent mimicked the human aorta post 
endovascular aneurysm repair. The centre of the aortic stent was equidistant at 81 mm 
from the viewing windows on all sides of the Perspex box.  
A second flow system of a significantly smaller diameter, simulating an endoleak was 
placed obliquely across the aortic stent.  The two flow systems were placed in such a 
way that they were exactly adjacent to each other at the point where they crossed over. 
A 2 mm inner diameter C-Flex® (Cole-Palmer, Walden, UK) tube was used for the 
smaller endoleak flow system.  
C-Flex is a unique thermoplastic elastomer with a tensile strength that, at a diameter 
of 2 mm, resists collapse under pressure from tissue mimicking material. Its physical 
properties (good tensile and shear strength, good biocompatibility and chemical 
resistance with low gas permeability and a smooth surface) made it an ideal material 
to be used for our ultrasound phantom. C-Flex has been validated for use in Doppler 
flow phantoms with its reported speed of sound of being 1557 m/s with an attenuation 
coefficient of 24.1 dB cm-1 MHz-1 at a frequency of 5 MHz (Teirlinck, Bezemer et al. 
1998, Browne, Watson et al. 2004, Brewin, Pike et al. 2008).  
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At the points of entry and exit of the small flow from the Perspex box, a 3mm 
stainless steel tube was used to connect the C Flex tubing within the phantom to the 
external circuit to prevent collapse of the second system and to make the phantom 
watertight (Figure 8). 
Perspex has a high ultrasound attenuation coefficient making it difficult to be able to 
view the Doppler flow phantom with the ultrasound scanner. A low density 
polyethylene (LDPE) viewing window was therefore built into each side of the 
Perspex box for the operators to scan the phantom. LDPE is a thermoplastic polymer 
made from ethylene with a low ultrasound attenuation coefficient. It is a flexible but 
tough material that is largely non-reactive at room temperatures. Five viewing 
positions were marked on the LDPE viewing windows that corresponded to five 
geometrical combinations of the main aortic flow and the small flow.  
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Figure 7: Photograph of the phantom in construction. EVAR graft deployed into the Perspex box. 
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Figure 8: Schematic of the phantom depicting the Perspex casing, the aortic and “endoleak” flow geometry and 
the LDPE viewing windows. 
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Assessments were performed in all the 3 planes [Proximal (second smaller flow 
proximal to the stent graft), distal (second flow distal to the stent-graft) and the 
tangential (second flow running tangentially across the stent-graft) planes] (Figure 9). 
To prevent the direction of endoleak flow from being perpendicular to the ultrasound 
beam in the proximal and distal planes, and to maintain the spatial arrangements at the 
specified viewing positions, the experiment was set up in such a way that the 
ultrasound transducer probe was placed at an arbitrary angle of 70° to the viewing 
window. A mobile visual guide was attached to the phantom that allowed the 
operators to align the ultrasound probe at the required angulation. For assessment of 
the tangential plane, the ultrasound probe was held perpendicularly to the LDPE 
viewing window. The visual guide could be moved to achieve this setting at all five 
viewing positions in all three planes. This arrangement corresponded to the cross 
sectional views as demonstrated in Figure 10. 
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 Proximal plane 
 
 
 
 
 
 Distal plane 
 
 
 
  
 Tangential plane 
 
Figure 9: Viewing position schematics for the three planes. For the proximal and distal planes, the probe was 
held at 70° to avoid the ultrasound beam being perpendicular to the direction of the small flow (numbers 
correspond to respective viewing positions).   
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Proximal Plane 
 
 
Distal Plane 
 
 
 
Tangential Plane 
 
 
Figure 10: Cross sectional schematics corresponding to the viewing positions in all the planes. Large circle 
corresponds to large flow and small circle to small flow. Numbers correspond to the viewing positions. (For 
depiction purposes only, actual distances between the small and large flows are as in table 1)  
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The distances between the two systems were predetermined and thus enabled 
experimental control (Table 6) 
Table 6:  Distances between large and small flows corresponding to the viewing windows for the three planes 
 Centre – Centre distance (mm) 
between large and small flows 
Edge – Edge Distance (mm) 
between large and small flows 
Positions 1 2 3 4 5 1 2 3 4 5 
Proximal  14.8 18.4 24.4 19.8 26.1 0.8 4.4 10.4 5.8 11.1 
Distal  15.9 24.4 34.9 26.9 37.7 2.9 10.4 20.9 12.9 23.7 
Tangential  22.8 16.6 14 16.6 22.8 8.8 2.6 0 2.6 8.8 
 
 
The depth of the large flow from the viewing window was constant at 81 mm for all 
planes. The depth of the small flow from the viewing windows was the same for all 
viewing positions for the proximal and distal planes respectively. For the tangential 
plane, the depths were as tabulated in Table 7. 
 
Table 7: Depths of the small flow from the viewing windows for the three planes 
Depth of small flow from viewing windows (mm) 
Positions 1 2 3 4 5 
Proximal 67 67 67 67 67 
Distal 95 95 95 95 95 
Tangential 63 72 81 90 99 
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Stent Graft 
 
A 24 mm inner diameter Medtronic Talent stent-graft was deployed within the TMM. 
The first reports of stent-graft deployment were by Parodi et al (Parodi, Palmaz et al. 
1991). Those initial stent-grafts were custom-made, hand-sewn devices that 
comprised a balloon expandable metallic stent sutured to overlapping Dacron® grafts. 
Stent-grafts have evolved enormously since those early days and are now complex 
devices with advanced delivery mechanisms. Stent-grafts nowadays are commonly 
composed of nitinol stents with Dacron grafts. The metallic stent forms the skeleton 
of the device. The Dacron component is required for the device to be impervious to 
blood, thus excluding the aneurysm sac from the circulation. Attachment of the stent-
graft to the aorta is by means of either hooks or barbs that attach it to normal aortic 
wall. Some devices attach to the aortic wall by means of radial force and polymer 
seals. Commonly used abdominal aortic stent grafts include the Medtronic Talent and 
Endurant® devices, the Gore® Excluder® device (W L Gore & Associates, Inc. 
Newark, Delaware, USA) and the Cook Zenith® device (Cook Group Inc., 
Bloomington, Indiana, USA). 
Our Doppler flow phantom utilised a Medtronic Talent aorto-uni-iliac stent-graft with 
internal diameter of 24 mm. Endoleaks, as described previously, are areas of flow 
within the aneurysm sac but outside the stent-graft and are classified into several 
types depending upon their origin.  From the point of view of Doppler ultrasound 
recognition of endoleaks, they could be considered to be a second flow visualised 
separate from the main aortic flow. This theme was used to design our phantom. A 
straight aorto-uni-iliac tube graft rather than a bifurcated stent-graft was therefore 
used in the phantom.  
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Pumps 
 
The small and large flows pumped blood-mimicking fluid through the phantom at 
different rates utilising two separate pumps. The larger ‘aortic’ system required high 
velocities to mimic the flow of blood through the human aorta. Flow rates through the 
human aorta vary from 1.5 to 6 L/min from the resting to the post exercise state 
(Chandran 1993). We aimed to reproduce the natural pulsatility and flow 
characteristics of the abdominal aorta as far as possible with a commercially available 
pump and thus used a Watson-Marlow 620U IP31 NEMA2 peristaltic pump (Watson 
Marlow Pumps, Falmouth, Cornwall, UK). This pump provided constant, pulsatile 
flow that mimicked blood passing through the human abdominal aorta. The flow rate 
through our stent graft was maintained at 14.4 cm/s, 3900 ml/min.  
The pump was set at 45 rpm that provided us with a simulated pulse rate of 90 beats 
per minute (Figure 10). As the pump revolutions increased, the maximum and 
minimum speeds started to diverge and the pulsatility of the flow became more 
apparent. At 45 rpm, the flow was pulsatile providing 90 beats per minute. At higher 
rpm’s the pulsatility of flow was more evident however this lead to the introduction of 
artefacts and they were not representative of the human heart rate. The pump setting 
was therefore programmed at 45 rpm, providing pulsatile flow and being 
representative of the human heart rate. 
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Figure 11:	  Graph to show blood flow speed in main flow against RPM of the pump (Maximum, minimum and 
time average mean) 
 
An IVAC 570 (CareFusion, San Diego, California, USA) infusion pump was used for 
the secondary flow. This pump provided a standard flow through the endoleak system 
and allowed the rate of flow to be experimentally manipulated. This enabled 
assessment of the impact of varying flow rates on determination of the presence of 
flow. 
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Tissue mimicking material 
 
Tissue mimicking materials, as the name suggests, mimic the ultrasonic properties of 
tissue and are used in the development of ultrasound phantoms. Ultrasound phantoms 
and tissue mimicking materials have been in existence or a long time. Several 
different materials have been used as TMMs such as soft plastics (plastisols, urethane 
polymers), gels and other polymers. The TMM used in our phantom was an agar 
based. The recipe had been put forth by Teirlinck et al (Teirlinck, Bezemer et al. 
1998) and conformed to the IEC 1685 draft specifications (International 
Electrochemical Commission) for flow Doppler test objects (International 
Electrotechnical Commission 2001). The composition of the TMM is detailed in 
Table 8.  
Table 8: Composition of tissue mimicking material 
Component Wight composition (%) 
Distilled water 82.97 
Glycerol 11.21 
Silicon Carbide (≈ 37µm) 0.53 
Aluminium oxide (3 µm) 0.94 
Aluminium oxide (0.3 µm) 0.88 
Rodalon (Benzalkonium Chloride) 0.46 
Agar 3.0 
 
The glycerol component of the TMM is responsible for providing the required speed 
of sound, the benzalkonium chloride prevents growth of microorganisms and the 
particulate matter composition (Al2O3 and SiC) modify the attenuation and 
backscatter (Ramnarine, Anderson et al. 2001, Brewin, Pike et al. 2008). The TMM is 
	   98	  
prone to desiccation and degradation that necessitates careful handling and adequate 
housing. To overcome these potential problems, our phantom was placed inside a 
Perspex casing. A dedicated port was also built into the housing to maintain hydration 
of the TMM.   
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Blood mimicking fluid 
 
A commercially sourced ATS 707 Doppler test fluid (ATS Laboratories Inc., 
Bridgeport, Connecticut, USA) was used as the blood mimicking fluid. Its physical 
properties are detailed in Table 9. 
Table 9: Physical properties of blood mimicking fluid 
Speed of sound 1571 m/s ± 1%  
Density 1.04 ± 0.01g/cc 
Viscosity 1.66 ± 0.1 centistokes 
Particulate size 30 ± 3 µm mean diameter 
Particulate concentration 1.7 ± 0.1x104 particles/cc 
 
The same blood mimicking fluid was circulated through both the aortic and endoleak 
flow systems care being taken to avoid any air bubbles to enter the system. 
 
 
  
	   100	  
Independent flow systems 
 
Two independent flow circuits were established, a large flow system with the aortic 
pump mimicking blood flow through the abdominal aorta and a small flow system 
representing the endoleak. The “heart” of the system was the aortic pump. Blood 
mimicking fluid draining from the aortic phantom was collected into a reservoir, from 
where it was cycled back into the inflow of the aortic pump (Figures 2 & 7). (needs 
updating) 
 
 
 
Figure 12: Large aortic flow 
EVAR	  Phantom	  
Reservoir	  
Aortic	  Pump	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The second system simulating the endoleak had a significantly smaller diameter. A C-
Flex tube with an internal diameter of 2 mm was used for this system. Blood 
mimicking fluid from a drop bag was pumped through this tube (inside the phantom) 
by an infusion pump (IVAC 570) and outflow from the tube collected and re-
circulated through the pump (Figures 2 & 8). 
 
 
 
Figure 13: Small endoleak flow 
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Phantom validation 	  
Our phantom was developed in conjunction with ultrasound physicists and 
sonographers who helped with the design of the phantom. These physicists and 
sonographers were also part of the team who carried out surveillance for the clinical 
arm of the study. The tissue mimicking material used for the phantom was agar based; 
the recipe had been developed by Teirlinck et al (Teirlinck, Bezemer et al. 1998). 
Browne et al (Browne, Ramnarine et al. 2003) assessed the acoustic properties of this 
agar based tissue mimicking material and found acoustic velocity to remain relatively 
constant despite increasing frequency of ultrasound. The attenuation demonstrated a 
liner response to increase in frequency. These characteristics were in line with 
recommendations made by the IEC 1390 standard (International Electrochemical 
Commission 1996).  
The acoustic properties of this tissue mimicking material at the frequencies used in 
our laboratory project had been determined by Brewin et al (Brewin, Pike et al. 2008). 
They demonstrated good agreement with expected values of the attenuation 
coefficient and speed of sound, with two independent laboratories confirming 
agreement. The spectral slope of the backscatter power also compared favourably 
with theoretical spectral slope values. The TMM retained its acoustic properties over 
a three-year period. We therefore decided on using this particular TMM as it had been 
tested and validated for use in an ultrasound phantom. Its properties were consistent 
and showed minimal degradation over time.  
Ultrasound flow models using TMM have been used and evaluated for recreating 
events within the human body. Browne et al (Browne, Watson et al. 2004) assessed 
and validated a sensitivity performance index test protocol, evaluating a range of 
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ultrasound scanners. The material that we used for our small flow system (C-Flex) 
was validated by the same group and has been proven to resist collapse despite being 
embedded in TMM.  
The flow systems and the general design of our phantom was developed in 
conjunction with ultrasonographers who were involved in the clinical part of our 
project and were familiar with the ultrasonic appearance endoleaks associated with 
the post EVAR aorta. The phantom was designed as a realistic physical interpretation 
of acoustic events within the human aorta post endovascular repair of aortic 
aneurysms.  
The validation of this phantom lay in its construction and design. The various 
components including the TMM and C-Flex had been chosen through previous 
research. Valuable input from the sonographers and physicists had helped with the 
designing of the flow systems specifically the concept of two independent flow 
systems, providing a non-anthropomorphic phantom that allowed for experimental 
control of our test variables. 
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Test design and setup 
 
Once assembled, the phantom was evaluated to ensure its compliance with the basic 
specifications of Doppler flow phantoms (Teirlinck, Bezemer et al. 1998, Browne, 
Watson et al. 2004). The phantom was also evaluated to assess whether it was able to 
provide the functionality required for assessing the limitations of DUS in the post 
EVAR setting.  
A number of different flow and geometrical configurations were assessed to establish 
the limits of flow in the small endoleak system that could be visualised by duplex 
(Browne, Watson et al. 2004). A test protocol was formulated in collaboration with 
ultrasound physicists, consisting of different geometrical and flow rate combinations 
(Table 11). The flow rates were established keeping in mind reported rates for slow 
and fast type II endoleaks (Arko, Filis et al. 2003) 
Prior to the phantom being assessed by the test operators, the phantom was evaluated 
by the ultrasound physicists to ensure that our experimental setup was a realistic 
representation of the ultrasonic appearance of events in the post EVAR aorta. After 
developing the test protocol (Table 11, Appendix 3 & 4), the phantom was bench 
tested with all the various flow and geometrical configurations (Table 11) and two 
sets of expected observations were derived 30 days apart.  These expected 
observations were graded on a scale of 0-3  
0 = no visualisation of flow 
1 = Possible visualisation of flow 
2 = Probable visualisation of flow 
	   105	  
3 = Definite visualisation of flow 
Doppler ultrasound diagnosis of the presence of an endoleak essentially depends upon 
detection of a smaller, second flow outside of the stent-graft, but within the native 
aneurysm sac. We extrapolated this concept to the visualisation of a small flow 
adjacent to a large stent-graft flow. Type 2 endoleaks are a result of back flow into the 
aneurysm sac from native branches of the aorta. These are typically small arteries 
such as the lumbar arteries or the inferior mesenteric artery. Back flow through these 
arteries is usually slow. Type 1 endoleaks are from the stent-graft attachment sites and 
have typically faster flow rates. Type 3 endoleaks are a result of modular disruption of 
the stent-graft and behave in a similar fashion to type 1 endoleaks tending to be faster. 
Several flow rates in the smaller ‘endoleak’ system were therefore assessed to 
ascertain the impact of flow rates on Doppler ultrasound detection of flow. 
Some endoleaks could be difficult to visualise due to their proximity and geometrical 
relationship with the main aortic flow. The phantom was designed keeping this in 
mind. The geometry of the phantom and the ability to rotate the phantom along the 
larger flows’ axis, allowed for assessment of several geometrical combinations of the 
small and large flows. The test protocol therefore consisted of assessments in three 
planes, with the smaller system running tangential, proximal and distal to the main 
aortic flow. The impact of proximity and the spatial relationships of the smaller and 
larger flows on visualisation of the small flow by DUS could thus be assessed. 
Another criticism of DUS as a surveillance modality has been its operator dependant 
nature. Several studies have reported varied success using DUS as a surveillance 
modality post EVAR, the variability being partly blamed on the operator dependant 
nature of DUS (Heilberger, Schunn et al. 1997, Sato, Goff et al. 1998, McWilliams, 
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Martin et al. 1999, Wolf, Johnson et al. 2000, Zannetti, De Rango et al. 2000, 
d'Audiffret, Desgranges et al. 2001, McWilliams, Martin et al. 2002, Giannoni, 
Palombo et al. 2003, Raman, Missig-Carrol et al. 2003, Elkouri, Panneton et al. 2004, 
Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006, Sandford, Bown et al. 2006). 
We attempted to assess whether the level of technical expertise of the DUS operator 
plays a part in detection of complications post EVAR. To ascertain this and to assess 
reproducibility of results by different operators, our study group consisted of three 
operators with varying levels of experience in performing vascular ultrasound 
(specifically post EVAR ultrasound).  
All our test operators were experienced in vascular ultrasound and were also part of 
the clinical arm carrying out surveillance Duplex scans for patients post endovascular 
aneurysm repair. However, their level of experience in performing post EVAR duplex 
surveillance varied from 1 year to 10 years. Two sets of observations were recorded 
for every operator 30 – 45 days apart. For the purposes of interpretation these two sets 
of observations recorded for each operator were treated as independent observations. 
Observers were asked to rate flow visualisation on a scale of 0-3 
All evaluations were preformed with an ATL HDI 5000 (Royal Philips Electronics, 
Amsterdam, Netherlands) ultrasound scanner. The Curvilinear C5-2 abdominal 
transducer was used for the assessments. This probe generates 2-5 MHz ultrasound 
signals, is curved and is typically used for assessments of the abdomen. The 
ultrasound scanner was pre-set to Abdominal EVAR protocol (Table 10) with similar 
settings as used to scan patients post EVAR, however the operators had freedom to 
vary the gain and Pulse repetition frequencies (PRF’s). During clinical 
ultrasonography, sonographers usually adjust gain and PRF’s to obtain the best 
	   107	  
possible views and minimize blooming of colour. Figure 14 depicts typical Doppler 
images of the phantom. 
The small vessel infusion bag was filled with blood mimicking fluid (ATS model 
707) and attached to the infusion pump (IVAC 750). Prior to initiating the test, the 
flow systems were cleared of any air bubbles. The outflow of the large ‘aortic’ flow 
automatically re-circulated through the priming tank. However, for the small 
‘endoleak’ flow system the outflow had to be manually collected and re-circulated 
through the phantom. 
Table 10: Pre-set ultrasound settings for scanning the phantom 
Probe C5-2 
Dynamic range  170 dB 
Compression Curve  2 
Persistence  Med 
2D Optimisation General 
Thermal index  0.4 
Mechanical Index  1.1 
 
The large vessel flow was connected to the aortic pump (Watson-Marlow 620U IP31 
NEMA 2 pump) that was set at a fixed rate of 45 rpm to simulate the heart beating at 
90 beats per minute. Prior to the test being initiated, the system was primed with the 
aortic pump running at 100 rpm for about 30-45 minutes with a wire mesh filter, 
placed over the reservoir outlet / pump inlet pipe, ensuring that any circulating residue 
remained within the priming tank and did not interfere with evaluations.   
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Table 11: Test protocol (Viewing positions correspond to figures 4 & 5. 10 observations per observer per plane, 
total of 180 observations were obtained) 
D
is
ta
l p
la
ne
 
Viewing 
position 
5 5 4 4 1 1 2 2 3 3 
Flow rate 
in small 
vessel 
(ml/hr) 
500 300 300 700 300 700 300 500 300 500 
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Viewing 
position 
1 5 2 4 3 1 4 4 5 2 
Flow rate 
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vessel 
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300 300 500 500 700 700 700 900 900 900 
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Viewing 
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5 5 4 4 1 1 2 2 3 4 
Flow rate 
in small 
vessel 
(ml/hr) 
500 300 300 700 300 500 300 500 300 300 
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Figure 14:	  Duplex appearance of the flow phantom   
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 The clinical arm  
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The clinical arm of our project aimed at identifying the limitations of duplex 
ultrasound for the detection of endoleaks in patients post EVAR. EVAR has been 
performed at Barts and The London NHS Trust since August 2000. Traditionally, 
similar to other centres throughout the world, surveillance for these patients was 
carried out with CT scans that were performed pre-discharge, at 6 weeks, 3 months, 6 
months, 12 months post procedure and then annually thereafter.  
Duplex ultrasound scanning was introduced into the protocol for surveillance of 
patients post EVAR for this study. A new surveillance protocol was designed that 
included both CT and duplex scans, ideally both scans being performed on the same 
day. As part of this new protocol, patients would undergo a CT scan and duplex scan 
on the same day at 6 weeks, 3 months, 12 months and annually after endovascular 
repair of their aneurysms.  
One hundred and thirteen patients underwent EVAR between August 2000 and 
August 2008 and were entered into our prospective trust-wide registry. Eighty-nine 
patients were male, with a mean age of 76.6 years (Table 12). The predominant 
device used for EVAR was the Cook Zenith endograft. This endograft is made of 
stainless steel stents that provide the exoskeleton for a woven polyester graft. The 
endograft employs supra-renal fixation, achieving proximal sealing with radial force 
and barbs that attach to the aortic wall. One hundred patients underwent elective 
repair of their aneurysms, thirteen were emergencies (2 symptomatic, 11 ruptures). 
Patients were followed up for an average of 18.5 months (range 3-91 months). 13 
patients died during the study period.  Another 7 patients were either lost to follow up 
or had their follow up scans at their local hospitals that were unavailable to us.  
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Table 12: Patient demographics 
Patients, n 113 
Demographics  
Mean age (range) years 
Gender, male (%) 
75.06 (51-91) 
84 (74.33) 
Device used (%)  
Cook 
Medtronic 
Gore 
Lemaitre 
Endologix 
74 (65.4) 
30 (26.5) 
7 (6.1) 
1 (0.8) 
1 (0.8) 
Timing of EVAR  
Elective 100 
Emergency  
                Symptomatic 
                Ruptures 
13 
2 
11 
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Compliance with instructions for use of these devices was compared with their 
anatomy as seen on their pre-operative CT scans (Table 13). Seven patients (6.1%) 
had anatomy that was outside the instructions for use for the corresponding endograft 
deployed.  
Table 13: Non compliance with device instructions for use 
Non-compliance with instructions for use (n=7) 
Neck length 2 
Angulation 4 
Neck diameter 1 
 
Two patients had short proximal neck lengths. One of these patients had been treated 
with the Cook Zenith endograft (neck length 10 mm) and the other with the Endologix 
Powerlink device (neck length 11 mm). 4 patients had proximal neck angulation that 
was more than specified by the respective instructions for use. 3 of these had been 
treated with the Cook zenith device (angle with the long axis of the aneurysm 64, 61 
and 75) and one with the Gore device (angle with the long axis of the aneurysm 75). 
One patient treated with the Medtronic device had a proximal neck diameter 
measuring 33 mm. 
Up to January 2006, patients had been followed up with regular CT scans as described 
above. Pre-discharge and 3 month post discharge, patients underwent either CT or 
DUS. These scans was performed depending upon the findings from the intra-
operative post-procedure angiogram or surgeon preference. Since January 2006, all 
patients in our EVAR registry underwent surveillance with both CT and DUS; scans 
being performed at 3, 6, 12 months post discharge and annually thereafter. It was 
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attempted to perform both the CT and duplex scans on the same day, however this 
was not always possible. Duplex and CT scans performed within 8 weeks of each 
were considered as paired scans for our study. All patients post EVAR also routinely 
underwent a pre-discharge duplex scan, CT being performed only if complications 
were detected on the duplex or at the completion angiogram. A 6-week scan was done 
at the discretion of the operating clinician, usually performed if the completion 
angiogram or pre-discharge scan revealed complications that warranted further follow 
up prior to the 3 month scan. Pre-discharge scans were included in our study if both 
the imaging modalities were performed within a week of each other. Similarly 6 week 
scans were included if the CT and DUS scans occurred within 3 weeks of each other.  
Endoleaks were defined as areas of persistent flow outside the stent but within the 
aneurysm sac and were classified as types 1-5 (Table 2) (Veith, Baum et al. 2002).  
All operators performing the duplex scans were blinded to the results of the 
corresponding CT scan. However, it was not always possible to blind the radiologists 
reporting the CT scans to the results of the duplex scans. This was especially the case 
when CT scans were performed as a result of findings of the duplex scans. Pre-
discharge CT scans were only performed when duplex scans reported complications. 
Scans that had been performed outside of the above surveillance protocol but were 
paired with corresponding CT or DUS scan as defined (Pre-discharge scan within 1 
week of each other, 6 week scan within 3 weeks of each other and for the other scans 
– within 8 weeks of each other). For the purposes of this study, unpaired scans were 
excluded from analysis. DUS scans that had been reported as suboptimal/inadequate 
were also excluded from analysis.  
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All endoleaks detected on either CT or DUS were discussed in a multi-disciplinary 
setting. Patients with endoleaks associated with aneurysm sac size enlargement were 
considered for further intervention. Sac size increase of more than 5mm were 
considered significant and decisions were made regarding further management 
depending on patient characteristics. Both the CT, DUS scans and reports were made 
available to the clinicians deciding on further management.  
Interventions performed included diagnostic catheter angiography, proximal or distal 
stent-graft extensions, embolisation, realignment, explantation and conversion. 
Patients that required interventions due to complications being detected on 
surveillance were re-entered into our surveillance protocol. All paired scans that had 
been performed between January 2006 and August 2008 were included in the study. 
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CT protocol 
 
The CT scan protocol traditionally favoured for post EVAR surveillance has been the 
triphasic protocol. This includes an initial non-contrast scan, an arterial first pass scan 
and a delayed phase scan (Rozenblit, Patlas et al. 2003). At our institution, to 
minimise radiation exposure for patients, routine surveillance scans were performed 
with only an arterial first pass scan. An initial non-contrast scan was performed for 
every patient prior to undergoing EVAR; this was used as a baseline for confirming 
areas of calcification on subsequent scans. A delayed phase scan was only performed 
if there was a suspicion of complications on the first pass scan.  
All scans were performed on a 64 slice multi-row detector CT scanner (Siemens 
Somatom). The protocol for abdominal aortic imaging was 0.6 mm slice collimation, 
5mm slice width, pitch factor of 1.2 and feed/rotation of 23.0 mm. there was a 10 -15 
sec delay for contrast injection for the arterial phase. Contrast was injected at a 3 – 3.5 
ml/s, and a total contrast dose of 100 – 120 ml was used.  
Post procedure surveillance CT scans were reviewed by one of four interventional 
radiologists who were part of the team performing endovascular aneurysm repairs at 
our institution. All scans were reviewed on a workstation with capabilities for multi-
planar reconstruction (MPR). Scans were reported to a standard protocol including the 
maximal aneurysm sac diameter, integrity and anatomical location of the sent graft, 
endoleaks and their source; and any other complications, if present. Endoleaks were 
classified as previously described (Table 2). Accurate endoleak classification was 
achieved by assessing the anatomical location of the endoleak, density of the endoleak 
and patency of the IMA, lumbar arteries. Comparisons were made with the non-
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contrast images and particular attention was paid to the sealing, overlap zones of the 
endograft (Gorich, Rilinger et al. 1999, Stavropoulos, Clark et al. 2005). Endoleaks 
related the proximal and distal attachment sites were classified as type 1, those related 
to the lumbar and inferior mesenteric arteries as type 2, whilst those originating 
adjacent to modular stent attachment sites were classified as type 3.  
All CT scans were also externally reviewed and validated to ascertain the origin of the 
endoleaks and adherence to reporting protocols. The external validator was blinded to 
the results reported by the vascular radiologists and the Duplex ultrasound results. 
There was agreement with the reported results in all but one case of a potential type 2 
endoleak that had resolved on subsequent scans. Figure 15 depicts a typical post 
EVAR CT angiogram with the arrow pointing to an endoleak. 
 
Figure 15: Typical appearance of CT angiogram post EVAR. Arrow depicting endoleak 
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Duplex protocol 
 
All duplex scans were performed at our dedicated vascular laboratory by a team of 4 
vascular ultrasound technologists. The scans were performed on an HDI 5000 Philips 
scanner till September 2007, since then the Philips iU22 scanner has also been used. 
Scans were performed using the 5-2 curvilinear abdominal probes. 
All post EVAR evaluations were performed to a pre-agreed protocol (Appendix 1, 2). 
This protocol was designed specifically for the purpose of this study in collaboration 
with the DUS operators and introduced as part of routine surveillance for patients post 
EVAR. 
The aorta was initially scanned using B-mode imaging from the diaphragm down to 
the femoral arteries in both the transverse and longitudinal planes, to determine the 
proximal and distal limits of the stent graft. The maximum aortic diameter during 
peak systole was recorded in this mode.  
Colour Doppler mode was then used to identify the renal arteries. The entire stent-
graft was visualised in colour Doppler mode, identifying any endoleaks, occlusions, 
kinking, significant stenosis of the stent and distal flow characteristics. Particular 
attention was paid to the proximal and distal stent attachment sites, the origins of the 
inferior mesenteric, lumbar and internal iliac arteries. Any flow visualised outside the 
stent, but within the aneurysm sac, was analysed using pulsed wave Doppler, to 
determine pulsatility of flow.  
For any endoleaks that were identified, attempts were made to trace them back to their 
source to enable classification. Endoleaks were classified as previously described 
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(Table 2). Scans were classed as being adequate, if the entire aneurysm sac was 
visualised and colour images of flow within the stent were obtained. In cases of 
inadequate scans, patients were asked to return to the vascular laboratory for a repeat 
scan in a few days. Figure 16 depicts a typical post EVAR Doppler image with an 
arrow pointing to the endoleak. 
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Figure 16:	  Typical appearance of post EVAR Doppler. Arrow pointing to endoleak 
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Statistical evaluation 
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Laboratory arm 
 
The Doppler flow phantom was designed to enable manipulation of the geometrical 
and flow characteristics of the small and large flow systems such that their impact on 
the reliable detection of flow in the small system could be assessed. The phantom 
could be rotated along the axis of the large flow enabling the small system to be 
effectively moved. The endoleak system could thus run proximal, distal or tangential 
to the large flow.  
For the purposes of statistical evaluation, one of the variables considered was the 
relative plane of the small flow to the large flow. This was categorised as small flow 
being proximal, distal or in the same horizontal plane as the large flow. When vertical 
planes were considered, the corresponding categories were small flow in the same 
plane as the large flow or in a different plane to the large flow. When considered in 
context of viewing positions and cross sectional schematics (Figures 5 & 6), the 
proximal and distal planes correspond to the proximal and distal planes used for the 
analysis; however, for the tangential plane, position 1 would be proximal, position 5 
would be distal and positions 2, 3 & 4 would be in the same plane as the large flow.  
Similarly for the vertical assessment planes, positions 1, 2 & 4 of the proximal and 
distal planes would be in the same plane as the large flow, positions 3 and 5 being in a 
different plane. Also, all the viewing positions for the tangential plane would be in a 
different vertical plane to the large flow. Thus the categories considered for the 
relative geometrical plane of the two flows were 
1) Endoleak system proximal to the aortic flow  
2) Endoleak system distal to the aortic flow.  
3) Endoleak system in the same horizontal plane as the aortic flow,  
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4) Endoleak system in the same vertical plane as the aortic flow, 
5) Endoleak flow in a different vertical plane to the aortic flow 
 
Univariate analysis 
 
The following parameters were considered whilst assessing the limitations of duplex 
ultrasound for the Doppler flow phantom. 
1. Flow rate in the second endoleak flow system 
2. Depth of the endoleak from the viewing window 
3. Distance of the endoleak from the main aortic flow 
4. Spatial relationships of the aortic and endoleak flows 
5. Operators 
As part of the clinical arm of our study, if any suspected endoleaks were detected on 
Doppler ultrasound, a further assessment was performed to confirm or refute findings 
if appropriate. The laboratory arm of the study intended to assess the limits of 
Doppler ultrasound in diagnosing endoleaks. Therefore, for the purposes of statistical 
evaluation, any flow visualisation in the small system was treated as flow being 
detected, even if the operator rated the flow as being possible or probable. Thus, 
endoleak detection scores of 1-3 were considered to represent endoleak flow being 
visualised and scores of 0 was regarded as absent endoleak flow. Statistical tests 
employed to determine significance of results were the chi-squared test and Fischer’s 
exact test. 
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Multivariate analysis 
 
The univariate analysis was employed to identify the variables that had a significant 
impact on the visualisation of flow in the small system. Multivariate analysis was 
performed using binary logistic regression analysis to understand the inter-
relationships between the variables and their impact on flow detection in the endoleak 
system. 
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Clinical arm 
 
CT was considered to be the gold-standard imaging modality for our study. Endoleaks 
detected on CT were classified as true endoleaks and those detected only on duplex as 
false endoleaks. The sensitivity, specificity, positive and negative predictive value of 
duplex was calculated assuming independence between individual paired scans. 
Kappa statistics were used to assess agreement between the two modalities for 
detecting endoleaks. 
Statistical analysis for comparing sac size estimation and agreement between the two 
modalities was performed using the Pearson correlation coefficient, Bland and 
Altman’s method and the paired Students t-test. 
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RESULTS 
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Laboratory results 
 
A total of 180 observations were obtained for the 30 different flow and geometrical 
configurations assessed by the test operators. These flow and geometrical 
combinations were designed to assess the limitations of duplex in the clinical setting 
of post EVAR surveillance. As described previously, the test protocol had been 
designed in consultation with ultrasound physicists who had also generated a set of 
expected results.  
Of the thirty combinations, flow detection was thought to be likely in 26 combinations, 
making it possible for flow to be detected in 156 instances. The test operators detected 
flow in 133 of these (Table 14). For the remaining 24 instances where flow detection 
was thought to be difficult, the test operators could detect flow in 10 instances. 
Table 14: Expected and actual visualisation of second flow 
 Expected visualisation of 
small flow 
Actual visualisation of 
small flow 
Flow seen 156 143 
No Flow seen 24 37 
 
Kappa statistic was found to be 0.36. A breakdown of these results according to the 
different variables assessed is expressed in Tables 11, 12, 13 & 14. 
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Table 15: Expected and actual visualisation for the different assessment planes 
Assessment plane Instances (n) Expected 
visualisation 
Actual visualisation 
Proximal 72 72 67 (93%) 
Distal 72 48 44 (92%) 
Same horizontal 36 36 32 (89%) 
Same vertical 78 60 60 (100%) 
Different vertical 102 96 86 (90%) 
 
Table 16: Expected and actual visualisation at different endoleak flow rates 
Rate of endoleak 
flow (ml/hr) 
Instances (n) Expected 
visualisation 
Actual visualisation 
300 78 60 59 (98%) 
500 48 48 39 (82%) 
700 36 30 29 (97%) 
900 18 18 16 (94%) 
 
Table 17: Expected and actual visualisation at different depths from the viewing windows 
Depth from 
viewing window 
(mm) 
Instances (n) Expected 
visualisation 
Actual visualisation 
63 12 12 11 (92%) 
67 60 60 56 (93) 
72 12 12 12 (100%) 
81 6 6 5 (83%) 
90 18 18 15 (67%)  
95 60 42 37 88% 
99 12 6 7 (116%) 
	   129	  
 
Table 18: Expected and actual visualisation at different distances of small flow from large flow 
Distance from 
aortic flow (mm) 
Instances (n) Expected 
visualisation 
Actual visualisation 
14 6 6 5 (83%) 
14.8 12 12 11 (92%) 
15.9 12 0 7 * 
16.6 30 30 27 (90%) 
18.4 12 12 10 (83%) 
19.8 18 18 17 (94%) 
22.8 24 18 18 (100%) 
24.4 18 18 16 (89%) 
26.9 12 6 5 (83%) 
34.9 12 12 9 (75%) 
37.7 24 24 18 (75%) 
* Incalculable; higher than predicted 
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Visualisation of flow at different flow rates of the endoleak 
 
 
Figure 17: Graph depicting endoleak visualisation as a function of endoleak rate of flow. 
 
Table 19 & Figure 17 demonstrate the visualisation of small flow at the flow rates 
depicted independent of the other variables. Tables 16, 17, 18 & 19 demonstrate flow 
detection in the small system for different small system flow rates, when considered 
in the context of the other variables i.e. operators, depth of the small system from the 
viewing window, distance between the two flow systems and the relative geometrical 
planes of the two flows. 
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Table 19: Flow detection based on flow rates in the small system 
Flow rate in 
the small 
system (ml/hr) 
Instances Detected % Detection 
300 78 59 75 
500 48 39 81 
700 36 29 81 
900 18 16 89 
 
Chi square statistics, p=0.616 
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Table 20: Breakdown of endoleak detection rates with varying endoleak flow speeds when considering the 
spatial arrangement of the large and small flows 
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Table 21: Endoleak detection as a function of flow rates and depth from the viewing window 
Depth of small 
flow from 
viewing 
window (mm) 
Endoleak flow 
rate (ml/hr) 
Instances Detected % Detection 
63 
300 6 5 83 
700 6 6 100 
67 
300 36 33 92 
500 18 17 94 
700 6 6 100 
72 
500 6 6 100 
900 6 6 100 
81 700 6 5 83 
90 
500 6 5 83 
700 6 5 83 
900 6 5 83 
95 
300 30 19 63 
500 18 11 61 
700 12 7 58 
99 
300 6 2 33 
900 6 5 83 
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Table 22: Breakdown of flow detection by flow rate and operator 
Operator Small system 
flow rate 
(ml/hr) 
Instances Detected % Detection 
1 
300 26 18 69 
500 16 13 81 
700 12 10 83 
900 6 6 100 
2 
300 26 21 81 
500 16 12 75 
700 12 9 75 
900 6 4 67 
3 
300 26 20 77 
500 16 14 88 
700 12 10 83 
900 6 6 100 
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Table 23: Endoleak detection as function of small system flow rate and distance between small and large flows 
Distance of 
small flow 
from large 
flow (mm)  
Small system 
flow rate  
(ml/hr) 
Instances Detected % Detection 
14 700 6 5 83 
14.8 
300 6 5 83 
500 6 6 100 
15.9 
300 6 4 67 
700 6 3 50 
16.6 
500 12 11 92 
700 6 5 83 
900 12 11 92 
18.4 
300 6 5 83 
500 6 5 83 
19.8 
300 12 11 92 
700 6 6 100 
22.8 
300 12 7 58 
700 6 6 100 
900 6 5 83 
24.4 
300 12 11 92 
500 6 5 83 
26.9 
300 6 1 17 
700 6 4 67 
34.9 
300 6 6 100 
500 6 3 50 
37.7 
300 12 9 75 
500 12 9 75 
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Visualisation at different distances from aortic flow 
 
 
Figure 18: Relationship between endoleak detection and distance between the large and small flows. 
 
Figure 18 depicts the relationship between flow detection in the small endoleak 
system and the distance between the small and large flows for all operators 
irrespective of the rate of flow in the endoleak system. Fishers exact test statistic was 
calculated and revealed a p value of 0.026. Table 23 also depicts the relationships 
between detection and distance between the flows, when small system flow rate is 
also factored in.  
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Visualisation of endoleak at different depths from the viewing window 
 
 
Figure 19: Relationship between depth of the endoleak flow from the viewing window and detection rates 
 
Detection of flow in the small system was assessed at different depths of the small 
system. The results, when flow detection was considered secondary to depth from the 
viewing window, independent of the other variables, are graphically depicted in 
Figure 19. Fisher’s exact test was used to assess the relationship between flow 
detection and depth of the small flow from the viewing window (p = 0.0002). 
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Visualisation at relative horizontal planes of endoleak and aortic flow 
 
 
Figure 20: Relationship between relative horizontal planes of small and large flow and detection of flow in the 
endoleak system 
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Visualisation by relative vertical planes of aortic and endoleak flows 
 
 
Figure 21: Relationship between relative vertical planes of small and large flows and detection of flow in the 
small system 
 
Figures 15 & 16 depict the relationship between detection of flow in the small system 
and the relative horizontal and vertical planes of the small and large flows at all small 
system flow rates. For the purposes of analysis, the spatial relationships between the 
two flows were assessed in the horizontal and vertical planes. Chi square test was 
performed and revealed a p value of 0.000003 for the horizontal plane assessment and 
>0.05 for the vertical plane assessment. 
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Visualisation by different operators 
 
 
Figure 22: Effect of operator experience on detection of flow in the small system 
 
The effect of operator experience on the detection of flow in the small system was 
studied. Figure 22 depicts this relationship for all flow rates in the small system and 
across all geometrical configurations. Chi square test revealed the p value to be >0.05. 
Detection of flow in the second system by the operators irrespective of the small 
system flow rates whilst altering the geometrical configurations of the two flows are 
tabulated in Tables 20, 21 & 22. 
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Table 24: Detection of small flow by operators categorised by relative planes of the two flows 
Operator Plane Instances Detected % Detection 
1 
Proximal 24 21 88 
Distal 24 14 58 
Same horizontal 12 14 100 
Same vertical 26 18 69 
Different vertical 34 29 85 
2 
Proximal 24 23 96 
Distal 24 15 63 
Same horizontal 12 8 67 
Same vertical 26 21 81 
Different vertical 34 25 74 
3 
Proximal 24 23 88 
Distal 24 15 63 
Same horizontal 12 12 100 
Same vertical 26 21 81 
Different vertical 34 29 85 
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Table 25: Detection of small flow by operators at various depths of the small flow 
Operators Depth from 
viewing 
window (mm) 
Instances Detected % Detection 
1 
63 4 3 75 
67 20 18 90 
72 4 4 100 
81 2 2 100 
90 6 4 67 
95 20 11 56 
99 4 3 75 
2 
63 4 4 100 
67 20 19 95 
72 4 4 100 
81 2 1 50 
90 6 3 50 
95 20 13 65 
99 4 2 50 
3 
63 4 4 100 
67 20 19 95 
72 4 4 100 
81 2 2 100 
90 6 6 100 
95 20 13 65 
99 4 2 50 
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Table 26: Detection of flow by the operators at various distances between the two flows 
Operators Distance of 
small from 
large flow 
(mm) 
Instances Detected % Detection 
1 
14 2 2 100 
14.8 4 3 75 
15.9 4 3 75 
16.6 10 10 100 
18.4 4 4 100 
19.8 6 5 83 
22.8 8 6 75 
24.4 6 4 67 
26.9 4 3 75 
34.9 4 3 75 
37.7 8 6 75 
2 
14 2 1 50 
14.8 4 4 100 
15.9 4 2 100 
16.6 10 7 70 
18.4 4 3 75 
19.8 6 6 100 
22.8 8 6 75 
24.4 6 6 100 
26.9 4 2 50 
34.9 4 3 75 
37.7 8 6 75 
3 
14 2 2 100 
14.8 4 4 100 
15.9 4 2 50 
16.6 10 10 100 
18.4 4 3 75 
19.8 6 6 100 
22.8 8 6 75 
24.4 6 6 100 
26.9 4 2 50 
34.9 4 3 75 
37.7 8 6 75 
 
Inter-observer agreement was studied using Cohen’s kappa statistic and was found to 
show κ = 0.21-0.4. Intra-observer variation was also studied comparing the two sets 
of observations for each operator. (κ = 0.21 – 0.4) 
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Clinical Results 
 
One hundred and thirteen patients underwent EVAR at our institution between August 
2000 and August 2008. A total of 305 CT and 296 Duplex scans were performed 
during follow up. Paired CT and DUS scans, defined as performed within 8 weeks of 
each other, were obtained in 190 instances (Figure 23) within a period of 11.2 days of 
each other (range 0 – 49 days).  
 
 
Figure 23: Distribution of paired CT and DUS scans 
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Table 27: Distribution of endoleaks, associated sac size change and need for intervention in our study 
population 
Patient Leak Seen on CT Seen on DUS Change in sac size Intervention 
1 Unclassified Yes No ↔ No 
2  Unclassified No Yes ↑ Yes * 
3 II No Yes ↓ No 
4 II Yes Yes ↔ No 
5 II No Yes ↔ No 
6 II No Yes ↔ No 
7 II Yes Yes ↔  No 
8 II No Yes ↓ No 
9 II No Yes ↓ No 
10 II Yes Yes ↓ No 
11 
I No Yes ↔  No 
II No Yes ↔  No 
12 II No Yes ↔  No 
13 I No Yes ↓ No 
14 Unclassified Yes No ↓ No 
15 Unclassified No Yes ↔  Yes ** 
16 II Yes Yes ↓ No 
17 II Yes No ↓ No 
18 I Yes Yes ↔  Yes 
19 II Yes No ↔  No 
20 II Yes No ↓ No 
21 I Yes Yes ↔  Yes 
22 II Yes Yes ↔  No 
23 I Yes Yes ↔  No 
24 II No Yes ↓ No 
25 I Yes Yes ↔  Yes 
26 II No Yes ↓ No 
27 I No Yes ↔  No 
28 I Yes Yes ↔  Yes 
29 II Yes No ↔  No 
30 
Unclassified Yes Yes ↔  No 
II Yes Yes ↔  No 
31 II No Yes ↔  No 
32 I Yes No ↑ Yes *** 
33 II No Yes ↔  No 
34 I Yes Yes ↔  Yes 
35 Unclassified Yes Yes ↓ No 
36 II Yes Yes ↔  No 
37 I Yes Yes ↔  No 
38 I Yes Yes ↔  Yes 
39 II Yes Yes ↔  No 
40 II Yes Yes ↔  No 
41 II Yes Yes ↔  No 
42 II Yes Yes ↔  No 
↔, ↓, ↑ - Indicates stable, decreasing and increasing sac sizes respectively   
* Unclassified endoleak seen on DUS, increasing sac size seen on both CT and DUS. Patient underwent realignment procedure 
for suspected endotension. 
** Unclassified leak seen on DUS, CT reported spontaneous thrombosis of this endoleak that had been previously visualised on 
an unpaired CT scan. Patient underwent device explantation after two failed endovascular interventions. 
*** Small type 1a endoleak of uncertain significance, associated with a 0.3 cm increase in sac size. Treated with a proximal 
extension cuff. 
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A total of 28 endoleaks were identified on CT in 27 patients. 9 were type 1, 15 were 
type 2 and in 4 cases CT could not adequately classify the endoleak. Of these, DUS 
identified 21 endoleaks, 8 were type 1, 11 were type 2 and 2 were of uncertain origin. 
An additional 16 endoleaks were identified by DUS in 15 patients, 3 were classified 
as type 1, 11 as type 2 and 2 of uncertain origin (Tables 23 & 24). 
Table 28: Distribution of endoleaks and agreement by modality 
Endoleaks visualised on 
both CT and DUS 
Endoleaks visualised only 
on CT 
Endoleaks visualised only 
on DUS 
21 
8 Type 1 
7 
1 Type 1 
16 
3 Type 1 
11 Type 2 4 Type 2 11 type 2 
2 Unclassified 2 Unclassified 2 Unclassified 
 
Eight out of 9 type 1 endoleaks identified on CT were detected on DUS. One type 1 
endoleak seen on CT but not on DUS was a small type 1a endoleak associated with a 
0.3 cm increase in diameter (Figures 19 & 20).   
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Figure 24: CT angiogram image for small leak seen only on CT (Arrow pointing to suspected endoleak) 
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Figure 25: Conventional catheter angiographic image (Arrow pointing to suspected endoleak) 
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Sensitivity, Specificity, Positive and Negative Predictive Value 
 
148/190 (77.9%) DUS and CT scans were concordant in terms of endoleak detection 
and 42/190 (22.1%) were discordant (Table 29) (Unweighted κ statistic 0.475) 
Table 29: Correlation between CT and DUS for diagnosis of endoleaks 
 
Using CT as the gold standard imaging modality EVAR surveillance and assuming 
independence between individual paired scans, we found DUS, in our practice, to 
have a sensitivity of 72.1%, specificity of 80.4%, positive predictive value of 50% 
and a negative predictive value of 91.4%.  
 
Aneurysm size 	  
As part of the clinical arm of the study we compared CT and DUS assessment of the 
AAA sac sizes. Maximal aneurysm diameter was measured using both CT and DUS 
at every patient attendance.  CT sac size estimation varied from 31 – 120 mm (mean 
55.32) as compared to DUS 36 – 105 (mean 50.31) (Figures 21 & 22) 
Sac size estimations were also carried out for serial paired scans that were obtained 
for 62 patients between 3 to 6 months apart. This varied from 0 to 18 for CT and 0 to 
11 mm for DUS (Figure 28). The change in sac size estimation in the time interval 
between the serial scans as assessed by both modalities was compared. (p = 0.9) 
 CT 
DUS Endoleak No Endoleak 
Endoleak 35 31 
No Endoleak 11 113 
	   150	  
 
Figure 26:  Correlation plot for absolute sac size estimation by DUS and CT 
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Figure 27: Bland Altman plot for CT – DUS size measurement (Dotted lines - 2 standard deviations) 
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Figure 28: Correlation plot for change in sac size with CT and DUS, p<0.05 (Serial paired scans obtained for 
62 patients, negative change indicates increase in size of sac) 
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DISCUSSION 
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At Barts and The London NHS Trust, we have had the benefit of a dedicated vascular 
ultrasound laboratory with 4 experienced vascular ultrasonographers who perform all 
our vascular scans. From the EVAR surveillance point of view, our study found DUS 
to be 72.1% sensitive and 80.4% specific, a positive predictive value of 50% and a 
negative predictive value of 91.4% for the detection of endoleaks considering CT to 
the gold standard imaging modality. 
 
Fate of endoleaks in our study population 
 
The clinical arm of the study found a total of 28 endoleaks in 27 patients detected 
with CT. Twenty-one of these endoleaks were seen on both CT and DUS, 7 were seen 
on CT alone. A further 16 endoleaks were visualised on DUS alone.  
 
Endoleaks detected on both CT and DUS 
 
Twenty-one endoleaks were detected and accurately classified on both CT and DUS. 
Eight of these were type 1 endoleaks, 7 type 1a and 1 type 1b. Six type 1a endoleaks 
required intervention whilst 1 type 1a and 1 type 1b had resolved spontaneously on 
subsequent follow up.  Eleven endoleaks were classified as type 2 on both CT and 
DUS. Of these, 10 were still present on the last paired scan. Two endoleaks of 
uncertain origin have resolved.  
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Endoleaks detected solely on CT  
 
One type 1 endoleak, 4 type 2 endoleaks and 2 leaks of uncertain origin were 
diagnosed solely on CT. The type 1 endoleak was detected on a 6 month follow up 
CT scan and had not been visualised on the paired DUS scan performed on the same 
day. This endoleak had also not been detected on any previous paired or unpaired CT 
or DUS scans. It was classified as a type 1a endoleak (Figure 24) and was associated 
with a slight increase in sac size. After discussion in our multi-disciplinary meeting, a 
decision was made to treat this endoleak. At catheter angiography there was 
continuing ambiguity about the significance of this small endoleak (Figure 25), but as 
it was associated with a 0.3 cm increase in sac size, a decision was made to treat this 
and a proximal extension cuff was deployed. 
Of the 4 type 2 and 2 uncertain origin leaks also detected only on CT, all except 1 
type 2 endoleak have resolved spontaneously or have been classified as artefacts on 
subsequent scans.  
 
Endoleaks detected solely on DUS 
 
Three type 1 endoleaks were detected solely on DUS. All of these were visualised on 
pre-discharge scans and had resolved on subsequent follow up. Of the 11 type 2 
endoleaks, 7 were still present on the last surveillance scan, 4 have resolved. Both the 
2 uncertain origin endoleaks required intervention. One patient underwent a 
realignment procedure and the second patient underwent an explantation procedure 
following two failed endovascular interventions. For both these patients, increasing 
	   157	  
sac size was identified by both modalities and the leaks had been visualised at other 
out of protocol, unpaired CT scans.  
For our study population, we were able to accurately detect all endoleaks that required 
intervention by DUS, except one endoleak. For this patient, there was ambiguity 
about the significance of this small type 1 endoleak that had been detected only on CT. 
There is a possibility that this endoleak was in fact an artefact visualised on both CT 
and catheter angiography. An increase in the aneurysm sac size increase of 0.3 cm 
could be regarded as an acceptable variation in aneurysm size measurements.  
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Endoleaks detected only on one imaging modality 	  
Table 30: Endoleak anatomy for leaks detected only on one modality 
Leak Visualised Leak anatomy Change in 
sac size 
Intervention 
Unclassified CT Posterior to graft (artefact) ↔ No 
Unclassified DUS Unclear (modular/type 3) ↑ Yes  
II DUS Lumbar ↓ No 
II DUS Lumbar ↔ No 
II DUS IMA ↔ No 
II DUS Lumbar ↓ No 
II DUS Lumbar ↓ No 
I DUS Type 1 a  ↔  No 
II DUS IMA ↔  No 
II DUS Lumbar ↔  No 
I DUS Type 1 a ↓ No 
Unclassified CT Posterior on pre-discharge scan 
(lumbar) 
↓ No 
Unclassified DUS Posterior (type 2 lumbar or type 
3) 
↔  Yes  
II CT Lumbar ↓ No 
II CT Lumbar ↔  No 
II CT Lumbar ↓ No 
II DUS Lumbar ↓ No 
II DUS Lumbar ↓ No 
I DUS Type 1 a ↔  No 
II CT Lumbar ↔  No 
II DUS Lumbar ↔  No 
I CT Type 1 a ↑ Yes  
II DUS IMA ↔  No 
 
Seven endoleaks were visualised only on CT and a further 16 endoleaks were 
visualised only on DUS (Table 30). All CT scans for these 23 patients with endoleaks 
detected only on one modality were reviewed. For patients with endoleaks diagnosed 
only on CT, the scans were analysed to ascertain the possible reasons behind failed 
detection on DUS. The one type 1 endoleak, detected only on CT, was found to be a 
small perigraft leak both on CT and at catheter angiography. However, continuation 
of the leak into the aneurysm sac could not be demonstrated on either the CT scan or 
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at catheter angiography. As this leak was associated with a small increase in sac size, 
and as there was a theoretical risk of this endoleak causing failure of the proximal seal, 
intervention was performed. The likely explanation for non-detection of this leak on 
DUS could be its relatively small size and the absence of communication with the 
aneurysm sac.  
4 type II leaks were missed on DUS. CT scan reviews for these patients demonstrated 
these type II leaks to be originating from lumbar arteries and to be in direct apposition 
with the stent-graft. All of these type II endoleaks were also small flow endoleaks on 
CT scans. The close proximity of the main aortic flow (stent-graft) to the endoleak 
and the relatively small size of these endoleaks could be the possible reasons behind 
their non-detection on DUS. One of these type 2 endoleaks was still present on the 
last follow up CT scan, others had all resolved at the last follow up scan. 
An additional 16 endoleaks were visualised on DUS alone. Two of these patients 
required intervention for increasing sac size identified on both modalities. For both 
these patients, the increasing sac size had been identified on both CT and DUS and 
the endoleaks had been visualised at other instances on CT, but these CT scans had 
either been performed out of protocol or were not paired with a DUS scan and were 
thus not included in the study. DUS operators had been unable to classify these 
endoleaks. On retrospective review of the paired CT scans the leaks were not visible 
but comparison of sac sizes with the previous CT scans did confirm enlargement of 
aneurysm sac size. 
3 type I endoleaks had been identified on DUS alone. All of these had been visualised 
on pre-discharge DUS scans. On review of the corresponding CT scans, these 
endoleaks could not be visualised. These leaks could also not be visualised on 
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subsequent paired DUS scans. In all these 3 cases, the DUS had preceded the CT scan 
by a few days. It is possible that these endoleaks had resolved by the time of the CT 
scan.  
A further 11 type II endoleaks were visualised on DUS alone. Paired CT scan review 
of all these endoleaks confirmed their absence on the scan. DUS reports of all these 
type II endoleaks revealed them to be relatively small flow endoleaks. Both IMA and 
lumbar endoleaks had been identified on DUS. 4 of these endoleaks had resolved on 
subsequent scans, 7 were sill present on the last scan.  
Duplex ultrasound is a dynamic imaging modality. DUS provides real time 
information as opposed to CT that provides static imaging albeit with excellent 
anatomic detail. The aorta/aneurysm interface is a dynamic area that responds to 
changes in the cardiac cycle and aortic wall compliance. It is possible that these slow 
flow endoleaks were not visualised on CT as the CT scan was out of phase with the 
endoleak. However, this remains an interesting area where further research is required.  
In all 14 type II endoleaks were detected only on one imaging modality. 3 of these 
endoleaks were a result of back perfusion of the sac from the inferior mesenteric 
artery, 11 (78.5%) resulted from lumbar artery back perfusion. Flow from lumbar 
arteries results in back perfusion of the sac and is likely to be posterior to the 
endograft with the patient in the supine position. All of these endoleaks were also 
reported to be slowly flowing or small endoleaks on DUS and CT scans respectively. 
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Reinterventions 	  
For our study population of 113 patients who underwent EVAR between August 2000 
and August 2008, 19 underwent re-interventions (Table 31). 9 of these were for 
endoleaks detected on either or both CT and DUS during our study period (Table 29). 
7 of these endoleaks were type 1a endoleaks that were treated with proximal 
extension cuffs.  
One patient underwent explantation of his endograft. This patient had a bifurcated 
endograft inserted originally but had presented with an increasing sac size 6 months 
post procedure. A diagnostic angiogram performed revealed a type 3 endoleak 
(previously unclassified on duplex, not visualised on CT) and underwent a bridging 
stent to cover the disruption of the original stent graft. A repeat scan a month later 
revealed a type 1a endoleak and proximal extension cuff was deployed. However a 
further emergency admission necessitated a laparotomy with explantation of the 
endograft.  
Another patient underwent a realignment procedure. This patient had an increasing 
sac size on both CT and DUS with an unclassified endoleak seen on DUS. The 
original EVAR had been performed 3 years prior to us instituting our study and the 
increasing sac size had been thought to be secondary to graft porosity, the patient 
subsequently undergoing a realignment procedure. 
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Table 31: Reinterventions 
Proximal cuff 9 
Iliac limb extension 4 
Embolisation of endoleak 1 (IMA) 
Realignment 1 
Endograft explantation 1 
Fem-fem cross over grafting 1 
Pseudoaneurysm repair 2 
 
2 patients had proximal cuff extensions that had been performed prior to our study 
period. 4 patients underwent iliac limb extensions but did not have any endoleaks 
detected by either modality. One patient underwent embolisation of his IMA. This 
patient had an emergency aorto-uni-iliac device inserted originally as an emergency 
for rupture. The surveillance CT and DUS scans had not detected any endoleaks. 
However, 6 months post procedure he underwent an out of protocol emergency CT 
for abdominal pain and was found to have an intra peritoneal thrombus with contrast 
extravasation into the abdomen that was in communication with the IMA. This was 
embolised.  
1 patient had to undergo a femoro-femoral crossover graft procedure for iliac limb 
thrombosis. Another 2 patients who had had aorto-uni-iliac devices with femoro-
femoral cross over grafts as their initial procedure had to have revisions of their 
femoral anastomoses for pseudoaneurysms.  
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IFU and complications post procedure 
 
7 of our patients had aneurysm anatomy outside of instructions for use for the device 
deployed (Table 13). 2 patients with short neck lengths had been treated outside 
instructions for use. Both these patients developed type 1a endoleaks that required 
proximal cuff extensions. One patient with neck angulation outside instructions for 
use (75°) also developed a type 1a endoleak that required a proximal cuff extension.  
The EUROSTAR investigators evaluated the importance of neck lengths on clinical 
outcomes (Leurs, Kievit et al. 2006) and found that neck lengths of less than 10 mm 
were associated with an increased incidence of type 1a endoleaks within 30 days of 
the procedure, also those with neck lengths less than 15 mm had a higher risk of being 
diagnosed with proximal endoleaks within 48 months of follow up. 
Schanzer et al (Schanzer, Greenberg et al. 2011) reviewed pre and post procedure 
scans of 10228 patients using the M2S database over a 10-year period and found that 
only 42% of their patients had anatomy that met the most conservative device 
instructions for use. Anatomy for 69% of their patients met the most liberal 
instructions for use. Their study end-point was aneurysm sac enlargement; that has 
been previously shown to correlate with the likelihood of developing complications 
(Fairman, Nolte et al. 2006, Lalka, Greenberg et al. 2009, Schanzer, Greenberg et al. 
2011). Although they did not present specific data for patients undergoing EVAR 
outside IFU and their rate of developing complications, 41% of their patients had 
aneurysm sac size enlargement.  
Other authors have argued that patients with unfavourable anatomy, specifically those 
with excessive proximal neck angulation, perform better with endografts that employ 
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supra-renal fixation (Robbins, Kritpracha et al. 2005). They evaluated 289 EVAR 
procedures performed using the Medtronic Talent endograft and categorized patients 
into four groups depending on their proximal neck angulation. Although they did find 
that device kinking was associated with proximal neck angulation, they did not report 
any significant difference between the groups in terms of increased incidence of 
complications such as endoleaks or migration.  
Lee et al (Lee, Ullery et al. 2013) evaluated 218 patients undergoing EVAR at a 
single academic centre. For 143 patients, anatomical characteristics met the device 
specific instructions for use. However, for 75 patients, that had been preferentially 
treated with the Cook Zenith device employing supra-renal fixation, anatomical 
characteristics were outside of the device specific IFU. They evaluated outcomes for 
these two groups and found that the latter group was more likely to be treated with 
proximal cuff extensions and needed increased fluoroscopy time intra-procedure. 
However, for their study, rates of complications such as migration, endoleaks and 
freedom from aneurysm related mortality were similar between the two groups.  
For our study we found that 3 of 7 patients that had been treated outside the device 
specific instructions for use required reinterventions (Table 32). All these patients had 
developed type 1a endoleaks that required proximal extensions with either cuffs or 
Palmaz stents® (Cordis Inc, Bridgewater Township, NJ, USA). 2 of these patients had 
been treated with devices that employ supra-renal fixation, whilst the patient with an 
angulated but of an adequate length neck had been treated with a device utilising 
infra-renal fixation.  
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Table 32: Reinterventions for procedures outside IFU 
Characteristic outside IFU Device Fixation Reintervention 
Short neck length (10 mm) Cook Supra-renal Proximal extension 
Short neck length (11 mm) Endologix Supra-renal Proximal extension 
Angulated proximal neck (70) Gore Infra-renal Proximal extension 
Angulated proximal neck (68) Cook Supra-renal None 
Angulated proximal neck (64) Cook Supra-renal None 
Angulated proximal neck (64) Cook Supra-renal None 
Neck diameter (33 mm) Medtronic Supra-renal None 
 
Overall for our study 19 (16%) patients underwent interventions. 7 patients were lost 
to follow up and 13 patients died during the course of the study. Cause of death could 
be determined for 7 cases, 5 patients died secondary to cardiac events, 2 patients 
succumbed on ITU having been admitted with graft related sepsis. 
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Paired CT and DUS scans 
 
Previous reports comparing CT and DUS for follow up of patients post EVAR have 
defined paired scans as those that have taken place from within the same day of each 
other to up-to six months apart (McWilliams, Martin et al. 1999, Wolf, Johnson et al. 
2000, McWilliams, Martin et al. 2002, Raman, Missig-Carrol et al. 2003, Elkouri, 
Panneton et al. 2004, Sandford, Bown et al. 2006). There has been some criticism of 
the time delay between the CT and DUS scans, as this could be responsible for 
discordant and unreliable results. Ideally, both the CT and DUS scans should be 
performed on the same day, but this is not always feasible. Even though our study 
defines paired scans as instances where both scans had been performed within 8 
weeks of each other, 140/190 (73.7%) of our paired CT and DUS scans were 
performed within 2 weeks of each other with the majority 111/190 (58.4%) being 
performed less than a week apart. Only 25/190 (13.2%) paired scans were performed 
more than 4 weeks apart.   
For our study, of the total 190 sets of paired scans, similar results were reported for 
both the CT and the paired DUS scan in 77.9% (148/190) of cases. For the remaining 
22.1% (42/190) discordant results were obtained between the CT and paired DUS 
scan. Nine of these 42 discordant scans had been performed at an interval of more 
than 4 weeks, twenty-five being performed within 2 weeks of each other.  
31 of the 42 discordant scans were actually DUS scans that had reported endoleaks. 
These were classified as false positives as for our study we had considered CT as the 
gold standard imaging modality. It is possible that these false positives could have 
actually been true endoleaks that have only been detected on duplex.  
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Aneurysm sac size estimation 
 
Similar to previous reports comparing aneurysm sac size estimation between CT and 
DUS, we found a statistically significant difference between the two investigative 
modalities (p<0.05) (Sprouse, Meier et al. 2003, Elkouri, Panneton et al. 2004). 
Although we found good correlation between CT and DUS for sac size estimation, the 
agreement between CT and DUS was poor (r=0.9, p<0.01) (Figure 26). Bland-Altman 
plot demonstrated that there was difference between the two modalities at all 
aneurysm diameters (Figure 27). The average difference between CT and DUS 
measurements for sac size for our sample was 6 mm, which is comparable with other 
studies assessing the two modalities for aneurysm sac size measurements (Sprouse, 
Meier et al. 2003, Manning, Kristmundsson et al. 2009). 
When patients undergo surveillance post endovascular repair, it is the change in sac 
size rather than the absolute sac size that determines the requirement for re-
intervention. Several authors have reported on predictors of sac size change post 
endovascular repair of abdominal aortic aneurysms. There is agreement that thrombus 
burden in the neck, adherence to IFU and the presence of an endoleak are important 
predictors of sac size change post EVAR. Types 1 and 3 endoleaks usually require 
urgent intervention. However, for type 2 endoleaks, the decision to intervene usually 
rests on sac size change, with intervention likely if sac size is increasing. Therefore, 
change in sac size rather than absolute sac size is an important predictor of the 
requirement for intervention.  
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We attempted to assess the change in sac sizes between the two modalities. For our 
study population, we were able to assess change in sac sizes for 62 patients with serial 
paired scans. These paired serial differences were normally distributed, statistical 
analysis with the paired students t test revealed no significant difference between CT 
and DUS measurements (p=0.9) (Figure 28). 
For our clinical study, 19 patients underwent reinterventions. 9 of these were for 
endoleaks detected on either CT or DUS during our study period. For 2 of these 
patients, an increasing sac size was detected by both modalities. The other 7 patients 
had no significant increase in sac size that had been detected on either modality. 
However, sac sizes had continued to remain similar to the last values.  
It is well recognised that endoleaks are a predictor of increasing sac size and as a 
consequence predict the risk of reintervention post EVAR. Intuitively, an increase in 
sac size usually warrants further investigations or close surveillance to enable 
assessment and intervention for the potentially life threatening complication of late 
aneurysm rupture post EVAR. Change in aneurysm sac size by inference is an equally 
important predictor for endoleaks. Our study found no significant difference between 
DUS and CT for the assessment of sac size change for serial paired scans obtained for 
62 patients. DUS surveillance   
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Assessment of the ultrasound phantom 	  
Univariate analysis 
 
Effect of varying endoleak flow rate 
 
The phantom allowed for assessment of flow detection in the small system whilst 
altering its flow rate. When evaluating visualisation as a function of flow rate in the 
endoleak system independent of the other parameters, the test operators were able to 
detect flow in 88.9% of all endoleaks at a flow rate of 900 ml/hr compared to 75.6% 
of endoleaks at 300 ml/hr (Figure 17). These results did not achieve statistical 
significance (p= 0.616) but were similar to those reported by other patient studies 
(Mirza, Karthikesalingam et al. 2010). 
A trend towards easier detection of high flow endoleaks was also demonstrable. This 
trend was also followed when breaking down results according to the relative planes 
of the large aortic flow and the small endoleak flow systems (Table 20). Evaluating 
flow detection in the subgroup where the small system is distal to the main aortic flow, 
the test operators achieved detection rates of 58.3% for endoleaks at 300 ml/hr, 61.1% 
at 500 ml/hr, 58.3% at 700 ml/hr and 83.3% at 900 ml/hr.  
 
Effect of varying geometry 
 
The phantom allowed us to manipulate the geometrical and spatial relationship of the 
two flow systems. Our results demonstrated statistical significance between two of 
these geometrical parameters namely, the distance between the two flow systems and 
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the relative horizontal plane of the small flow compared to the large flow; and flow 
detection in the small system. Fisher’s exact test and Pearson’s chi square tests 
revealed statistical significance (p = 0.026, 0.0002 respectively). 
When assessing detection of flow in the small system relative to its distance from the 
large flow, it was noted that at distances 15.9 mm, 26.9 mm of the endoleak flow from 
the aortic flow, detection of flow in the small system was difficult (Figure 18). This 
corresponded with the predicted results generated by the ultrasound physicists prior to 
the phantom being assessed by the test operators (Table 18). At these two distances of 
the small and large flows, the second system was distal to the large flow. This also 
corresponds with the results obtained by assessing the relative horizontal planes of the 
small and large flows where it was found that flow detection was difficult in the distal 
plane especially in the presence of a small flow rate in the second system. We also 
found a significant relationship between the depth of the second system and detection 
of flow in the small system (p = 0.0002) (Figure 19) with detection of flow becoming 
difficult with increasing depth of the second flow system.  
The third variable assessed to evaluate the effect of altering the geometrical 
relationship on flow detection was the relative vertical plane of the small flow to the 
large flow (Figure 21). Analysis of this variable did not reveal any statistically 
significant difference in small flow detection whether the small flow was in the same 
or a different vertical plane to the large flow.  
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Figure 29: Scatter plot depicting the relationships of the significant variables and flow detection in the small 
flow (mean detection, smooth curve through data) 
 
Figure 29 is a visual representation of the effect of varying geometrical and endoleak 
flow rates on detection of flow by the operator. It depicts the relationships of the three 
significant geometrical variables affecting flow detection in the second system, with 
flow detection becoming increasingly difficult with increasing depth and distance of 
the endoleak flow from the viewing window and from the large flow respectively. The 
vertical axis represents flow detection. The horizontal axis represents the changes in 
the independent variables affecting flow detection. Detection of the endoleak flow 
also becomes difficult when the second system is in a plane distal to the large flow.   
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Effect of operator experience 
 
The comparative data obtained from the study of the phantom, evaluating the same 
geometrical and flow rate combinations (Figure 22), for the three test operators did 
not reveal any statistically significant difference for flow detection (p=0.6). Despite 
the considerable difference in experience for the test operators and contrary to 
published research, our results did not reveal any significant difference in detecting 
complications between different operators for the post EVAR aorta.  
However, assessing for intra and inter observer agreement, we could only demonstrate 
fair agreement. Cohen’s kappa analysis was performed to assess this agreement 
between the operators.  Κ values ranged from 0.21-0.4 when assessing both inter and 
intra-observer agreement. We also assessed for agreement between the operators and 
predicted results that were achieved by the clinical physicists. Again, kappa analysis 
demonstrated fair agreement (κ=0.36). 
Our results are reflective of what has been reported in terms of the operator dependant 
nature of ultrasound (Table 5). The clinical physicists involved with the project had 
limited clinical experience compared with our test operators who had regular clinical 
contact and substantial experience in vascular ultrasonography. This might explain the 
failure to achieve higher levels of agreement with the predicted results. However, 
even when assessing inter-observer and intra-observer agreement, our results indicate 
only fair agreement for detection of flow.  
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Multivariate analysis 
 
Univariate analysis was performed to identify the variables that had a statistically 
significant impact on flow detection in the small system. Pearson’s chi square and 
Fishers exact tests were employed to identify depth of small flow from viewing 
window, distance between the large, small flows; and the relative horizontal planes of 
the small and large flows as the statistically significant variables impacting flow 
detection.  
Table 33: Multivariate analysis performed using binary logistic regression analysis using significant variable 
identified through univariate analysis 
 
B S.E. Wald df Sig. Exp(B) 
95% C.I. for 
Exp (B) 
Lower Upper 
Horizontal 
plane 
 
.660 .474 1.936 1 .164 1.935 .764 4.901 
Distance from 
aortic flow 
 
.010 .029 .127 1 .722 1.010 .955 1.069 
Depth from 
viewing 
window 
 
-.097 .024 16.621 1 .000 .908 .866 .951 
Constant 8.137 1.590 26.182 1 .000 3418.361   
 
Multivariate analysis was performed using binary logistic regression. The model was 
statistically significant and was able to explain 22% of the variance observed 
(Nagelkerke R2). The whole model fit test proved that there was statistical 
dependence between the above variables and prediction of flow detection (p = 0.0002, 
U = 0.2). The lack of fit test did not reveal statistical significance supporting the view 
that adding more variables would be unlikely to make a difference to the predictive 
model. The likelihood ratio tests confirmed the statistical significance of depth of the 
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endoleak from the viewing window as the variable predicting flow detection (Table 
33). 
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The results from our assessment of the Doppler flow phantom have demonstrated that 
depth of the endoleak from the viewing window has a significant impact on flow 
detection. We also established that endoleaks that are present in a plane distal to the 
large artic flow are more difficult to diagnose.  
Clinical research has suggested that slow flowing endoleaks are difficult to diagnose 
(Mirza, Karthikesalingam et al. 2010). Our test protocol was designed with a higher 
number of assessments at slower flow rates of the endoleak system.  Even though our 
results analysing the impact of endoleak flow rates on detection did not reveal 
statistical significance, we did demonstrate a trend toward detection of flow in the 
second system being difficult with reduced flow in the endoleak system. It is possible 
that with increasing the number of test scenarios or operators, we might have been 
able to demonstrate statistical significance. Multivariate analysis, however, does 
suggest that increasing the number of variables would be unlikely to have any 
significant impact on the predictive model.  
The clinical arm of our study demonstrates that DUS can be effective in diagnosing 
complications post EVAR. It has value in detecting a change in aneurysm sac size, 
although as reported by several other authors, it tends to underestimate aneurysm sac 
sizes as compared to CT (Sprouse, Meier et al. 2003, Elkouri, Panneton et al. 2004).  
For the clinical part of or study we were able to diagnose all complications requiring 
intervention and our results for sac size estimation are also in keeping with previous 
published reports. The results from our clinical arm, therefore, support the use of 
Duplex ultrasound in post EVAR surveillance protocols. 
 There have been reports of improvements in the sensitivity and specificity of duplex 
ultrasound with the introduction of contrast (Heilberger, Schunn et al. 1997, 
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McWilliams, Martin et al. 1999, McWilliams, Martin et al. 2002, Giannoni, Palombo 
et al. 2003, Napoli, Bargellini et al. 2004, Henao, Hodge et al. 2006). Ultrasound 
contrast media such as sulphur hexafluoride (Sonovue) and galactose / Peflutren and 
albumin (Optison) are gas filled, stable micro-bubbles with a high degree of 
echogenicity, that cause an increase in backscatter. The improvement in complication 
detection rates with contrast though, has not been uniform. McWilliams et al 
(McWilliams, Martin et al. 1999) compared contrast-enhanced duplex (CED) with 
arterial phase CT and reported excellent results, but the same group could not 
reproduce these results when comparing biphasic CT and CED (McWilliams, Martin 
et al. 2002). A further recent study, using a continuous contrast infusion technique 
found CED to be comparable to CT (Henao, Hodge et al. 2006). Our study did not 
employ contrast enhanced ultrasound, but the Doppler flow phantom provides a good 
opportunity for further research into whether the addition of ultrasound contrast offers 
any significant advantages over unenhanced ultrasound in this group of patients. 
Management of abdominal aortic aneurysms is a constantly evolving field with 
technology being constantly updated. Older generation stent grafts such as those used 
by Parodi et al (Parodi, Palmaz et al. 1991) have been replaced with newer ones. New 
concepts in devices such as the Nellix system (Endologix inc, Irvine, California, 
USA) are also being trialled that may revolutionise the endovascular management of 
aneurysms. With all this advancement major complications post EVAR are rare, but 
this has also resulted in complex cases, that would previously have not been thought 
to be amenable for endovascular grafting, being considered for EVAR. Wider 
exposure and information dissemination has also implied that patients are more 
inclined towards having minimally invasive surgery and increased the number of such 
procedures being performed.  The need for surveillance of patients post procedure 
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therefore remains of utmost importance. Endoleaks, originally thought to be a difficult 
problem has gained better understanding. Type 2 endoleaks that are not associated 
with an increase in aneurysm size are mostly managed conservatively.  
Several centres now routinely perform post EVAR surveillance with Duplex, with CT 
or catheter angiography being performed in cases of ambiguity or complications 
(Harrison, Oshin et al. 2011). Another recent study has suggested basing post EVAR 
surveillance on early results, eliminating the 6 month scan; and yearly surveillance 
with Duplex ultrasound for patients without initial complications (Sternbergh, 
Greenberg et al. 2008). A recent survey of post EVAR surveillance practices in the 
UK has revealed heterogeneity in post EVAR surveillance (Karthikesalingam, Page et 
al. 2011) indicating a continuing lack of consensus amongst vascular centres.  
Screening for abdominal aortic aneurysms has been discussed in detail over the last 
few years (Kyriakides, Byrne et al. 2000, Ashton, Buxton et al. 2002, Cosford and 
Leng 2007).  It has also been suggested that screening for abdominal aortic aneurysms 
will be associated with a modest increase in the overall surgical workload of hospitals 
(Kyriakides, Byrne et al. 2000). Increased aneurysm detection will translate into an 
increased number of patients undergoing EVAR for their abdominal aortic aneurysms. 
With abdominal aortic aneurysm screening now being performed in the UK, the time 
is right for the introduction of a DUS based surveillance protocol of patients post 
EVAR. Such a protocol may include both CT and DUS for the first year, subsequent 
surveillance being performed only with DUS. CT scans could be performed in cases 
where complications are detected on DUS. Contrast enhanced duplex needs to be 
investigated further and may provide information to help drive down both costs and 
radiation exposure to patients from EVAR surveillance. 
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In conclusion the results form our phantom have demonstrated that certain types of 
endoleaks are more difficult to diagnose on ultrasound. Duplex ultrasound offers 
advantages over other modalities for post EVAR surveillance, however its role in its 
current form, is more likely to be complimentary to other imaging modalities such as 
CT. 
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Future Work 
 
Our laboratory work has revealed results suggesting that the depth of the endoleak 
from the viewing window is the most important predictor of the determination of flow 
in the endoleak system. The next step for the project would be to assess the impact of 
introduction of ultrasonic contrast media into the flow systems. This may lead to 
increased detection of endoleaks that have proven elusive to the non-contrast model. 
For the clinical arm, selected patients with endoleaks that were missed on Duplex 
could be evaluated further by means of contrast-enhanced duplex to ascertain if these 
endoleaks were to become apparent. 
These investigations could prove a definitive increase in sensitivity of DUS for the 
detection of endoleaks and other complications in the post EVAR setting. Another 
area of future development could be the assessment of the ultrasound phantom as a 
training modality for vascular ultrasonographers. The phantom could be developed 
further with this in mind and may become a useful training tool. 
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Appendix 1: Protocol for Ultrasonographers 
 
Surveillance Scan of Endovascular Abdominal Aortic Aneurysm Repair Stents 
Important Note: 
-The previous duplex reports and CT scans should not be referred to for any patient 
-All scans should be videotaped with ONLY the patient number displayed on the 
screen.  Do not enter the patient’s name onto the new patient screen at the beginning 
of the scan 
B-Mode: 
-Using B-mode, image the aorta in longitudinal and transverse planes to determine the 
proximal and distal limits of the graft. 
-Using B-mode, image the aorta in several different planes (transverse, longitudinal), 
and take several diameter measurements of the aortic sac during peak systole.  Note 
and report the maximum aortic sac diameter seen at peak systole. 
Colour and Pulsed-Wave (PW) Doppler: 
-Using colour Doppler try to image the renal arteries and make a note of how many 
renal arteries are visualised, and on which side. 
-Using colour Doppler set at  PRFs appropriate to eliminate aliasing or confirm 
occlusion where necessary, image the stent, the common iliac arteries and the external 
iliac arteries down to the level of the inguinal ligament. 
-Note any occlusion, significant stenosis or kinking of the stent and iliac arteries. 
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-Using colour Doppler set at a PRF of approx. 13cm/sec and colour gain set just 
below the level where background noise appears as colour on the screen, image the 
entire length of the stent in longitudinal and transverse planes. 
-Pay particular attention to the posterior aspect of the sac for lumbar artery origins, 
and pay particular attention to the anterior aspect of the distal sac for the IMA. 
-If any colour is displayed outside the stent, within the aneurysm sac, use PW Doppler 
to determine if this colour represents artefactual noise, or if it is pulsatile.   
-Take thermal images of any suspected endoleak in colour and with its PW spectrum.   
-Try to determine source of endoleak (proximal or distal end of graft, IMA or lumbar 
branch, defect in graft).  
-Once the source of endoleak has been identified the endoleak can be classified and 
reported as Type I (failure of the graft to attach properly at either end, resulting in 
flow back into the sac from the proximal or distal end of the graft), Type II 
(retrograde flow into the sac from an aortic branch, i.e. lumbar or IMA) or Type III 
(defect in graft, i.e. a tear in the graft material). 
Adequacy and Quality of Scan: 
-Determine and note whether or not the scan was adequate: an adequate scan will 
yield views of the entire aneurysm sac and colour images of flow within the stent.  If 
either of these are not seen, the scan is inadequate. 
- Note the quality of the scan: 
1- All views poor 
2- Most views poor 
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3- Half views clear 
4- Most views clear 
5- All views adequate. 
 
- Complete the Post-EVAR surveillance Duplex report worksheet  
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Appendix 2: Duplex report worksheet 
	  
	  
Post EVAR Surveillance Duplex 
 
Patient Name: 
 
 Date:  
Hospital Number:  
DOB:  
 
 
Adequacy of scan:  
(Adequate scan: Entire sac and flow 
within graft visualised) 
Adequate  
 
 
Reason for inadequate scan: 
 
  
 
Maximum sac diameter (cm): 
(Peak systolic, in any direction, in any plane) 
 
 
Renal arteries visualised: Both 
 
Endoleak seen: No 
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Description of Endoleak: 
(Include Type and Origin) 
 
 
 
Graft Patency: Patent 
 
Stenosis/Kinking:  
 
Quality of scan (1-5): 
(1 – All views poor, 2 – Most views poor, 3 – Half views clear,  
4 – Most views clear, 5 – All views adequate) 
5 
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Appendix 3: Phantom setup 
 
EVAR test object protocol (Tester/Controller) 
Set up  
ATL HDI 5000 – Power up scanner. Press “scan head” and select correct probe (C5-
2) and protocol “Abdominal – EVAR”. 
SMALL VESSEL – Fill the small vessel drop bag with blood mimicking fluid (ATS 
Model 707). Ensure that there are no air bubbles in the line by releasing it from the 
infusion pump and undoing pipe clamp. Also ensure that there are no kinks in the line. 
Fluid should flow into the blood mimic beaker. Once flow is seen tighten pipe clamp. 
Re-attach the line into the infusion pump and close. Turn on the infusion pump. Set 
the rate to 300 ml/hr. In order to start the pump, press “run/hold” 5 times. Should 
alarm sound, this could be because of air in the tube or the drip monitor is not in 
position.  
LARGE VESSEL – Turn on the aorta pump. Set the rate to 45 rpm. Press start. 
Ensure that there are no air bubbles or visible particulates in the vessel. In order to rid 
the system of these anomalies, release the pipe join in reservoir an run peristaltic 
pump at 100 rpm with wire gauze held over reservoir outlet/pump inlet pipe. Once 
blood mimic has been cleared, re-attach the pipe join whilst ensuring not to introduce 
further air into the system. 
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Plane 2: 
Set up in following order: position, small flow (ml/hr) 
1. 1,300; 2. 5,300; 3. 2,500; 4. 4,500; 5. 3,700; 6. 1,700; 7. 4,700; 8. 4,900; 9. 5,900; 
10. 2,900 
Plane 1: 
Set up in following order: position, small flow (ml/hr) 
1. 5,500; 2. 5,300; 3. 4,300; 4. 4,700; 5. 1,300; 6. 1,700; 7. 2,300; 8. 2,500; 9. 3,300; 
10. 3,500 
Plane 3: 
Set up in following order: position, small flow (ml/hr) 
1. 5,500; 2. 5,300; 3. 4,300; 4. 4,700; 5. 1,300; 6. 1,500; 7. 2,300; 8. 2,500; 9. 3,300; 
10. 4,300 
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Appendix 4: EVAR test (Operator protocol) 
 
EVAR test – observer protocol 
Position oneself comfortably in seat and ensure that the controls are handy. Select the 
curvilinear probe (C5-2) and rotate the phantom so that scan plane 2 is on top. Fill 
well with distilled water. Place probe at scan position 3 with probe perpendicular to 
phantom. Set 2D gain so that tissue background corresponds to middle of greyscale 
bar. When image is maximised for greyscale, the HD zoom should be used to focus 
on the area surrounding the stent. It may be necessary to revert to full screen at times 
in order to check the angling of the probe.  
Once the test begins, the colour flow should be switched on and positioned over the 
aorta stent vessel with edges of box approx. 2 cm away from it in all directions. The 
colour should then be optimised so that the small flow can be visualised using the two 
controls: colour gain and colour PRF. Start each test with the PRF set high and the 
colour gain set low. Increase the gain until the point where the colour in that large 
vessel is not leaking outside its perimeter. Adjust/reduce PRF until small flow can (or 
cannot) be seen.  
One will be asked to assess how well the small vessel is visualised in relation to the 
big vessel. This should be scored: 0 = no visualisation, 1 = possible visualisation, 2 = 
probable visualisation, 3 = definite visualisation. One should also note down the gain 
and PRF settings, which can be altered for each position.  
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Plane 2: 
This test is performed with the probe at right angles to the acoustic window. Use 
probe guide at pinned positions in order to set the angle and position.  
“PERFORM TESTS” 
Empty the well using the large syringe. Wipe excess water with paper towels. Rotate 
the phantom to scan plane 1. Fill well with distilled water. 
Plane 1: 
This test is performed with the probe at 70° angle to the acoustic window. Use angle 
guide at pinned rail positions to set the transducer angle to 70°. 
“PERFORM TESTS” 
Rotate the phantom to scan plane 3. Use angle guide at pinned rail positions to set the 
transducer angle to 70° and set transverse position. 
Plane 3: 
This test is performed with the probe at 70° angle to the acoustic window. Use angled 
edge of probe guide at pinned positions in order to set the angle and position. 
“PERFORM TESTS” 
Empty the well using the large syringe. Wipe excess water with paper towels. 
 
 
  
	   214	  
 
